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CHAPTER 2
ADIPOSE TISSUE-DERIVED 
MESENCHYMAL STEM CELL YIELD 
AND GROWTH CHARACTERISTICS 
ARE AFFECTED BY THE TISSUE-
HARVESTING PROCEDURE 
MJ Oedayrajsingh-Varma, SM van Ham, 
M Knippenberg, MN Helder, 
J Klein-Nulend , TE Schouten, 
MJPF Ritt and FJ van Milligen
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Adipose tissue-derived mesenchymal stem cell 
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1 Department of Plastic Reconstructive and Hand Surgery, VU University Medical Center, Amsterdam, the Netherlands, 2 Department of 
Immunopathology, Sanquin Research at CLB, Amsterdam, the Netherlands, 
3Department of Oral Cell Biology, ACTA-Vrije Universiteit, 
Amsterdam, the Netherlands, 4Department of Orthopaedic Surgery, VU University Medical Center, Amsterdam, the Netherlands and 'Department 
of Pathology, VU University Medical Center, Amsterdam, the Netherlands 
Background 
Adipose tissue contains a stromal vascular fraction that can be easily 
isolated and provides a rich source of adipose tissue-derived 
mesenchymal stem cells (ASC). These ASC are a potential source of 
cells for tissue engineering. We studied whether the yield and growth 
characteristics of ASC were affected by the type of surgical procedure 
used for adipose tissue harvesting, i.e. resection, tumescent liposuction 
and ultrasound-assisted liposuction. 
Methods 
Frequencies of ASC in the stromal vascular fraction were assessed in 
limiting dilution assays. The phenotypical marker profile of ASC was 
determined, using flow cytometry, and growth kinetics were 
investigated in culture. ASC were cultured under chondrogenic and 
osteogenic conditions to confirm their differentiation potential. 
Results 
The number of viable cells in the stromal vascular fraction was 
affected by neither the type of surgical procedure nor the anatomical 
Introduction 
In many mature organs such as brain, intestines, BM and 
adipose tissue, a fraction of cells in the connective tissue 
remains undifferentiated [1,2]. This subpopulation of 
stromal cells contains progenitor cells and mesenchymal 
stem cells (MSC), fibroblast-like cells that can differentiate 
upon chemical or physiologic stimulation and play an 
important role in tissue remodeling and repair [3]. 
site of the body from where the adipose tissue was harvested. After all 
three surgical procedures, cultured ASC did express a CD34+ 
CD3r CD105+ CD166 + CD45- CD90 + ASC phenotype. 
Huwever, ultrasound-assisted liposuction resulted in a lower frequency 
of proliferating ASC, as well as a longer population doubling time of 
ASC, compared with resection. ASC demonstrated chondrogenic and 
osteogenic differentiation potential. 
Discussion 
We conclude that yield and growth characteristics of ASC are � 
by the type of surgical procedure used for adipose tissue harvesting. 
Resection and tumescent liposuction seem to be preferable above 
ultrasound-assisted liposuction for tissue-engineering purposes. 
Keywords 
adipose tissue, limiting dilution assay, mesenchymal stem cells, 
population doubling time, resection, tissue engineering, tumescent 
liposuction, ultrasound-assisted liposuction. 
Adipose tissue is derived from the mesodermal germ 
layer, similar to BM, and contains a supportive stroma 
that can easily be isolated [4,5]. This stromal fraction of 
adipose tissue consists of a heterogeneous mixture of 
cells, including endothelial cells, smooth muscle cells, 
pericytes, fibroblasts, mast cells and pre-adipocytes 
[6]. In addition, like in the BM, the stromal vascular 
fraction of adipose tissue contains a population of 
24
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multipotent adipose tissue-derived mesenchymal stem 
cells (ASC) [6]. 
After isolation of the stromal vascular fraction from the 
adipose tissue, ASC can be expanded in culture towards a 
homogeneous cell population for extended periods [6,7]. 
The cultured cells show low levels of cell senescence and, 
importantly, maintain their multipotency towards the 
mesenchymal lineage [ 6,8]. Cultured ASC have the 
capacity to differentiate into adipocytes [6,7], chondro­
cytes [6,7,9,10], osteoblasts [11,12], myocytes [7], neuronal 
cells [13,14] and cardiomyocytes [15]. During the past 
several years, there has been growing interest in the 
applicability of ASC for stem cell technology and future 
cell-based therapies such as tissue engineering. 
Adipose tissue is available in large quantities and is 
easily obtained via surgical procedures. The three most 
commonly used procedures are resection, tumescent or 
conventional liposuction and ultrasound-assisted liposuc­
tion, which mostly aim at the improvement of the body 
contour [16-18]. With tumescent liposuction, the donor 
material is infiltrated with a mixture of adrenaline and 
lidocaine, causing vasoconstriction and anesthesia. Ultra­
sound-assisted liposuction, introduced by Scuderi et al. in 
1987 [19], employs the use of ultrasonic energy to allow 
selective destruction of subcutaneous adipose tissue [20-
22]. 
All three surgical procedures, resection, tumescent 
liposuction and ultrasound-assisted liposuction, result in 
minimal patient discomfort and little donor site morbidity. 
However, the potentially detrimental effect of the surgical 
procedures on functional characteristics of ASC has not 
been investigated yet. 
In this study we tested whether the yield and growth 
characteristics of ASC were affected by the type of surgical 
procedure used for adipose tissue harvesting, i.e. resection, 
tumescent liposuction and ultrasound-assisted liposuction. 
First, the yield of viable cells in the stromal vascular 
fraction of the adipose tissue obtained by the three 
different surgical procedures, and from different anatomi­
cal sites, was determined. The frequency of functional ASC 
in stromal vascular fraction cell isolates exhibiting growth 
characteristics specific for MSC was determined in limit­
ing dilution assay. The fraction of cultured cells exhibiting 
a CD34 + CD31- CD105 + CD166 + CD45- CD90 + 
MSC phenotype was assessed using flow cytometry. 
Finally, we investigated whether the surgical procedure 
used for adipose tissue harvesting affected the growth 
kinetics of cultured ASC. ASC were cultured under 




Human subcutaneous adipose tissue samples were ob­
tained as waste material after elective surgery and donated 
upon informed consent of the patients by the departments 
of plastic surgery from various clinics in the Netherlands. 
Adipose tissue was taken from the abdomen (n = 16), hip 
and thigh region ( n = 11) and mamma n = 4) during 
cosmetic surgery. Twenty-nine female donors and two 
male donors (mean age 39, range 9-81 years) were 
included in the study. The body mass index was 27.0 ± 
0.8 (mean± SEM). 
Resection, tumescent liposuction and 
ultrasound-assisted liposuction 
Resection, tumescent liposuction and ultrasound-assisted 
liposuction were used to obtain adipose tissue from the 
abdomen, hip and thigh region and mamma. For resection, 
the material was cut out en-block under general anesthesia. 
For tumescent liposuction, a hollow blunt-tipped cannula 
was introduced into the subcutaneous space through 
a small incision. A 0.65% NaCl saline solution (Baxter, 
Utrecht, the Netherlands), supplemented with the 
vasoconstriction agents epinephrine CF (1 mg/mL; 
Centrafarm, Etten-Leur, the Netherlands), prilocaine 
HCl (1.5%; Pharmacy, VU University Medical Center, 
Amsterdam, the Netherlands) and kenacort-AlO (10 mg/L; 
Bristol-Myers Squibb, New York, NY, USA), was infused 
into the adipose compartment to minimize blood loss and 
tissue contamination by peripheral blood cells prior to 
aspiration. The adipose tissue was mechanically disrupted 
by moving the cannula through the adipose compartment, 
and the liposuction material was aspirated by gentle 
suction. For ultrasound-assisted liposuction, the subcuta­
neous adipose tissue was infiltrated with 0.9% saline 
solution supplemented with 1 % xylocaine and 0.001 % 
adrenaline (Spruyt hillen, IJsselstein, the Netherlands). 
Ultrasound-assisted liposuction was performed using the 
Lysonix 2000 Ultrasonic System with an operating 
frequency of 22.5 kHz ( ± 500 Hz) and a hollow cannula 
(Gilliland Etching, type Mercedes; Mentor Benelux, 
Weesp, the Netherlands). The liposuction material was 
2
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aspirated under 27.5 Hg vacuum with series 250 aspirator 
(Lygonix, Carpinteria, CA, USA). 
Cell isolation and storage 
The crude lipoaspirate or resected tissue was transported 
from the operation room to the laboratory in sterile transportation bags within 2 h post-surgery. The resected 
material was minced using a surgical scalp, and the weight 
of the tissue was determined. To isolate the stromal 
vascular fraction, the adipose tissue was washed extensively 
with PBS, followed by enzymatic digestion with 0.1 % 
collagenase A (Roche Diagnostics GmbH, Mannheim, 
Germany) in PBS containing 1 % BSA, for 45 min at 
37°C under intermittent shaking. The digested adipose
tissue was then washed with DMEM-glucose (BioWhit­
taker, Cambrex, Verviers, Belgium) containing 10% FBS 
and centrifuged for 10 min at 600 g. The cell pellet was 
resuspended in PBS and passed through a 200-µm mesh 
(Braun/ Beldico s.a-n.v, Marche-en-Famenne, Belgium) to 
remove debris. Subsequently, cells were subjected to Ficoll 
density centrifugation (lymphoprep, p = 1.077 g/mL, 
osmolarity 280 ± 15 mOsm; Axis-Shield, Oslo, Norway) 
to remove contaminating erythrocytes. Ficoll density filtration was performed after the first 10 isolations, as it 
improved the flow cytometric analyses of the samples 
without affecting the yield of viable cells in the stromal 
vascular fraction (data not shown). The cell-containing 
interface was harvested and washed with DMEM contain­
ing 10% FBS. The viability of the cells was assessed using 
trypan blue exclusion assay. Viable, large cells were counted using light-microscopy. After the isolation proce­
dure 3-10 x 106 cells were resuspended in a mixture (1:1) 
of culture medium and cyroprotective medium (Freezing 
Medium; BioWhittaker), frozen under 'controlled rate' 
conditions in a Kryosave (HCI Cryogenics BY, Hedel, the Netherlands) and stored in the vapor phase of liquid 
nitrogen according to standard practice in the Department 
of Pathology of the VU University Medical Center, and 
following the guidelines of current good manufacturing 
practice. 
Culture and growth kinetics of ASC 
Single-cell suspensions of cryopreserved SVF cells were seeded at 4-12 x 104 cells/cm2 in DMEM supplemented 
with 10% FBS, 100 U/mL penicillin, 100 µg/mL 
streptomycin, 2 mM L-glutamine (Gibco, lnvitrogen, 
CA, USA) and 1.8 µg/mL amphotericin B (Fungizone, 
Bristol-Meyers Squibb Company, New York, NY, USA). 
The cultures were maintained in a 5% CO2 incubator at 37°C in a humidified atmosphere. The medium was
changed twice a week. When reaching 80-90% con­
fluency, cells were detached with 0.5 mM EDTA/0.05% 
trypsin (Gibco, Invitrogen) for 5 min at 37°C and replated.
Cell viability was assessed using the trypan blue exclusion assay. 
To determine the growth kinetics of cultured ASC, 10 
T25 flasks per donor were seeded with 1 x 105 cultured 
ASC (passage 2 or 3 ). At several time points (between days 
2 and 12) after seeding, cells from two duplicate flasks 
were harvested and cells were counted. ASC numbers were 
plotted against the number of days cultured, and the 
logarithmic growing phase of the cells was determined. 
The population doubling time was calculated using the 
formula: ( days in logarithmic phase)/ ((logN 2 - logN 1) / log2), where N 1 is the number of cells at the beginning of the logarithmic growing phase and N2 the number of cells at the end of the logarithmic growing phase. 
Limiting dilution assay 
To assess the frequency of ASC in the stromal vascular 
fraction of adipose tissue, the stromal vascular fraction 
cells were seeded in DMEM with 10% FBS and antibiotics 
in 96-well plates at 15 x 103 cells/well in the upper row. 
Two-fold dilution steps of the cells were made in the 
following rows. All cultures were performed in duplicate. 
After 3 weeks each single well was individually scored on 
the basis of the number of cells. A well containing a cluster 
of at least 10 adhered, fibroblast-like cells was considered 
positive. The frequency of ASC was calculated from the 
rows of cells, of which 2 5 -7 5 % of the wells were scored 
positive. 
Flow cytometry 
Cultured ASC (passage 1 or 2) were used for flow 
cytometric analyses. Cells were trypsinized and resus­pended in flow cytometry buffer (PBS containing 0.1 % BSA and 0.02% natrium azide). Aspecific binding was 
blocked by incubating the cells with 20% human im­
munoglobulin ( a kind gift of the Department of Hematol­
ogy, VU University Medical Center) for 3 min on ice. 
Samples of 0.1 x 106 cells were incubated with allophyco­
cyanin (APC)-conjugated MAb against CD34 (clone 3812; 
BD Biosciences, San Jose, CA, USA), FITC-conjugated 
MAb against human CD31 (BD Biosciences Pharmingen, 
26
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San Diego, CA, USA) and PE-conjugated MAb against 
CD105 (clone SN6; Caltag Laboratories, Burlingame, CA, 
USA), CD166 (clone 3A6; RDI Research Diagnostics, 
Flanders, NJ, USA), CD45 and CD90 (clone 5El0; BD) 
for 20 min on ice in a dark environment. Isotype-matched 
FITC-conjugated MAb, PE-conjugated MAb and APC­
conjugated MAb (DAKO Cytomation, Glostrup, Denmark) 
served as negative controls. After washing, the cells were 
analyzed on a fluorescence-activated cell sorter (FACSCa­
libur; BD). Data acquisition and analysis were performed 
using Cell Quest software (BD). Expression levels of 
surface markers of interest were calculated using the 
formula for the mean fluorescence ratio (MFR): (mean 
fluorescence (MF))investigated IgGI-Ab/(MF)1gGl-isotype conttol. When MFR was higher than 2, the cells were considered 
positive for the marker of interest. 
Chondrogenic and osteogenic differentiation 
Chondrogenic and osteogenic differentiation were induced 
in ASC obtained by resection and tumescent liposuction, 
using the micromass culture technique (n = 3). In short, 50 
µL of a concentrated ASC cell suspension (8 x 106cells/ 
mL, passage 2) were plated on a glass slide and allowed to 
attach at 37°C for 1 h. Chondrogenic medium, consisting 
of DMEM, containing ITS+ TM Premix (final concentra­
tion in medium when diluted 1:100, insulin 6.25 µg/mL, 
transferrin 6.25 µg/mL, selenous acid 6.25 ng/mL, BSA 
1.25 mg/mL, linoleic acid 5.35 µg/mL; BD), 20 ng/mL 
transforming growth factor- �1 (TGF-�1 ; Biovision, ITK­Diagnostics, Mountain View, CA, USA), 100 nM dexa­
methasone only on the first day, 1 % FCS, 25 µm 
ascorbate-2-phosphate (Sigma, St. Louis, Missouri, USA), 
100 U/mL penicillin, 100 µg/mL streptomycin and 2 mM 
L-glutamine, was overlaid gently.
For osteogenic differentiation, ASC (passage 2) were
seeded at 5000 cells/cm2 and cultured in monolayer in 
osteogenic medium, consisting of normal culture medium 
supplemented with 10 mM �-glycerol phosphate, 50 µg/ 
mL ascorbic acid and 100 ng/mL bone morphogenetic 
protein 2 (BMP-2; Peprotech EC Ltd, London, UK). 
Osteogenic media were changed twice a week, chondro­
genic media every other day. 
Reverse transcription PCR 
Total RNA from the cells was isolated using TRizol® 
reagent (Invitrogen, Carlsbad, CA, USA). cDNA synthesis 
(GeneAmp® PCR System 9700; PE Applied Biosystems, 
Foster City, CA, USA) was performed using 0.5-1 µg total 
RNA in a 20-mL reaction mix containing 5 U transcriptor 
reverse transcriptase (Roche Diagnostics), 0.08 A260 units random primers (Roche Diagnostics) and 1 mM of each 
dNTP (Invitrogen). The cDNA was stored at - 80°C 
prior to real-time PCR. 
Real-time PCR reactions were performed using the 
SYBRGreen reaction kit according to the manufacturer's 
instructions (Roche Diagnostics) in a LightCycler (Roche 
Diagnostics). Primers (lnvitrogen) used for real-time PCR 
are listed in Table 1. For real-time PCR, the values of 
relative target gene expression were normalized for 
relative 18S housekeeping gene expression. Amplified 
PCR products were electrophoresed on a 2 % agarose gel 
and stained with EtBr. 
Histochemistry and immunohistochemistry 
Cell nodules that were formed under chondrogenic culture 
conditions were washed with PBS, fixed in 4% parafor­
maldehyde for 1 h and embedded in specimen-processing 
gel (HistoGel, Richard-Allan Scientific, Kalamazoo, MI, 
USA). This was then dehydrated and embedded in paraffin. 
Paraffin sections ( 4 µm) were dried, deparaffinized, 
rehydrated and then stained with Alcian blue (Sigma) at 
acidic pH for detection of proteoglycans. For the detection 
of collagen type II, sections were first predigested with 
PBS containing 1 % hyaluronidase (Sigma, St Louis, MO, 
USA) and 0.1 % pronase (Merck, Darmstadt, Germany), 
both for 30 min at 37°C, washed with PBS and subse­
quently treated with 0.3 % hydrogen peroxide in methanol 
for 30 min. Non-specific background was blocked with 
PBS containing normal rabbit serum (1:50; DAKO) and 1 % 
BSA for 30 min. Sections were incubated overnight at 4 °C 
with mouse MAb II-116B3 (1:50; Developmental Studies 
Hybridoma Bank, Iowa City, Iowa, USA) against human 
collagen type II in PBS containing 1 % BSA. Following 
washing with PBS, sections were incubated for 30 min with 
biotin-conjugated rabbit Ab against mouse immunoglobu­
lins RaMBioF(ab')2 (DAKO), followed by a 30-min 
incubation with ABC-HRP (1:1000; DAKO Cytomation). 
The sections were then treated with biotin tyramide for 15 
min and again incubated with ABC-HRP (1:200). Finally 
color development was achieved using 3,3-diaminobenzi­
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Table 1. Primer sets used for reverse transcription PCR 
Gene Primer sets Accession number, product length (hp) 
Col2A1VARA Forward -5' GGATGGGCAGAGGTATAATG 3' Reverse -5' GGTCCTTTGGGTCCTACAA 3' Human, NM_001844, length 255 bp Human, NM_001135, length 160 bp 
Human, AF052124, length 181 bp 
Human, NM_000088, length 195 bp 
Human, NM_l0098, length 151 bp 




Forward -5' TTCCAAGTAAGTCCAACGAAAG 3' Reverse -5' GTGACCAGTTCATCAGATTCAT 3' Forward -5' AAGCCGAATTCCTGGTCT 3' Reverse -5' TCCAACGAGATCGAGATCC 3' Forward -5' GTAACCCGTTGAACCCCATT 3' Reverse -5' CCATCCAATCGGTAGTAGCG 3' 
Statistics 
Data were analyzed using SPSS package 11.0 (SPSS, Inc., 
Chicago, IL, USA) and Kyplot 2.0 (Freeware). Based on the 
Kolmogorov-Smirnov test, our data were normally dis­
tributed within the donor population. Therefore, one-way 
ANOVA was used to determine significant differences between the means when three groups within one variable 
were compared. Means between two groups in one variable 
were compared using the independent sample t-test when 
the one-way ANOVA showed significant differences (P < 0.05). 
Results 
Effect of tissue harvesting site and surgical 
procedure on the yield of stromal vascular 
fraction cells 
We first investigated whether the anatomical location from 
which the adipose tissue was retrieved did affect the yield 
and viability of the isolated stromal vascular fraction cells. 
Adipose tissue was harvested from the abdomen, hip and 
thigh region and mamma. The yield of stromal vascular 
cells for the abdomen was 0.7 x 106 ± 0.1 x 106 cells/g 
adipose tissue (mean± SEM, n = 16), the hip and thigh 
region 0.5 x 106 ± 0.07 x 106 cells/ g ( n = 11) and the 
mamma 0.6 x 106 ± 0.3 x 106 cells/ g ( n = 4 ). The yield of 
viable cells was not dependent on the donor site from 
which the adipose tissue was harvested (Figure 1 ). Adipose 
tissue harvested from the breasts was sometimes contami­
nated with either glandular or connective tissue, which 
possibly obstructed cell isolation and/ or cell counting, 
resulting in a very low cell yield in one case and in a very 
high cell yield in another case. To avoid this problem, we 
have only used adipose tissue from the hip/thigh region 
and the abdomen to assess the effect of the surgical adipose 
tissue harvesting procedure on the yield of the stromal 
vascular fraction cells. 
The trypan blue exclusion assay was used to determine 
cell viability after adipose tissue dissociation, and revealed 
that 81 ± 2 % ( mean ± SEM) of the cells were viable. There 
were no differences in cell viability between the adipose 
tissue harvesting procedures. The numbers of viable cells 
harvested were for resection 0. 7 x 106 ± 0.1 x 106 cells/ g 

























Figure 1. Numbers of viable stromal vascular fraction cells obtained 
per gram of adipose tissue, harvested from the abdomen, hip and thigh 
region and mamma. Viable cells were identified by trypan blue 
exclusion. Each dot represents a SVF cell isolation; the line indicates 
the mean SVF cell yield. No significant differences in yield of SVF cells 
between the donor sites were found (P = 0.3; one-way ANovA). AT, 
adipose tissue; SVF, stromal vascular fraction. 
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(n =13) (n =11) (n =6) 
Figure 2. Numbers of viable stromal vascular fraction cells obtained 
per gram of adipose tissue, after using resection, tumescent liposuction 
and ultrasound-assisted liposuction. Adipose tissue was harvested from 
the abdomen or hip/thigh region. Viable cells were identified by trypan 
blue exclusion. Each dot represents a SVF cell isolation; the line 
indicates the mean SVF cell yield. No significant differences in yield of 
SVF cells between the operative procedures were found (P = Q69; one­
way ANOVA). AT, adipose tissue; RS, resection; SVF, stromal vascular 
fraction; T-LS, tumescent liposuction; US-LS, ultrasound-assisted 
liposuction. 
tion 0.5 x 106 ± 0.1 x 106 cells/g (n = 8) and ultrasound­
assisted liposuction 0.6 x 106 ± 0.2 x 106 cells/g (n = 6) 
(Figure 2). There was a large variation in the numbers of 
cells obtained between the different donors tested. How­
ever, the average yield of viable cells was the same for all 
three surgical procedures investigated. This demonstrated 
that the three surgical procedures investigated provided 
similar and high numbers of viable stromal vascular 
fraction cells. 
Effect of the surgical procedure used on the 
frequency and growth kinetics of ASC 
Limiting dilution assays of stromal vascular fraction cells 
were performed to investigate whether the adipose tissue 
harvesting procedure did affect the frequency of functional 
ASC in the stromal vascular fraction, able to adhere and 
proliferate in vitro. In the stromal vascular fraction of 
resected adipose tissue, 6.3 ± 1.8% (n = 6) of the cells did 
adhere and showed proliferative capacity. In the stromal 
100.------------� 
� 10 0 
0 
0 






0.01 t 0 u. P= 0.03 j 
0.001 
RS T-LS US-LS 
(n=6) (n=6) (n= 5) 
Figure 3. Effect of the adipose tissue harvesting procedure on the 
frequency of ASC in the stromal vascular fraction. Adipose tissue was 
harvested using resection, tumescent liposuction or ultrasound-assisted 
liposuction, and stromal vascular fraction cells were isolated. The 
frequency of ASC in the stromal vascular fraction isolates was 
determined using limiting dilution assay. Wells were scored after 21 
days. A well containing > 10 adhering cells with a fibroblast-like 
morphology was scored positive. Rows of the 96-well plate were used in 
calculation of frequencies of ASC when 25- 75% of the wells were 
scored positive. A significant difference (P < 0.05; independent sample 
t-test) was � in ASC frequency between adipose tissue harvested 
using ultrasound-assisted liposuction and adipose tissue harvested by 
resection. ASC, adipose tissue-derived stem cell; RS, resection; T-LS, 
tumescent liposuction; US-LS, ultrasound-assisted liposuction. 
vascular fraction obtained by tumescent liposuction, 1.9 ±
1.3% (n = 6) of the cells did adhere and proliferate, and by 
ultrasound-assisted liposuction 0.4 ± 0.1 % (n = 5) (Figure 
3). The ASC frequency was significantly different between 
adipose tissue obtained by resection and ultrasound­
assisted liposuction (P= 0.03). 
To investigate the effect of the surgical procedure on 
the growth kinetics of cultured ASC, cells were expanded 
in vitro and the population doubling time of cells in 
passage 2 or 3 was determined. The cells reached 
approximately 90% confluency in 1 week. However, 
when the stromal vascular fraction cells were obtained 
via ultrasound-assisted liposuction, the cells needed 
several weeks of culture to reach the same degree of 
confluency (data not shown). To confirm that each cell 
2
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culture contained equal numbers of ASC at the start of 
the growth kinetics experiment, the frequency of cells 
exhibiting a CD34 + CD31- CD105 + CD166 + CD45-
CD90 + phenotype was determined using flow cytometry
(Figure 4 ). The frequencies of cells exhibiting an ASC phenotype were similar in cultures derived from resection, 
tumescent liposuction and ultrasound-assisted liposuction 
material. When adipose tissue was obtained by resection or 
tumescent liposuction, a cell-growing curve was obtained 
showing a logarithmic growing phase, where after the cells 
reached confluency (Figure 5a,b). The mean population doubling time of the ASC in the logarithmic growing 
phase was 2.6 ± 0.3 days (mean± SEM, n = 7) when the 
adipose tissue was harvested using resection, and 2.8 ± 0.64 
days ( n = 4) when the tissue was harvested using tumes­
cent liposuction (Figure 5d). However, when adipose tissue was harvested by ultrasound-assisted liposuction, the 
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(Figure 5c). The population doubling time of ASC was 21.9 ± 5.5 days (n = 5) and was significantly longer when 
compared with the population doubling time of cells 
obtained by resection (P = 0.002) or tumescent liposuction 
(P= 0.01). The cell doubling time of ASC was similar 
when adipose tissue was harvested by resection and 
tumescent liposuction (Figure 5d). 
Chondrogenic and osteogenic differentiation 
potential of cultured ASC 
ASC obtained from adipose tissue harvested by resection 
and tumescent liposuction were verified for their chon­
drogenic and osteogenic differentiation potential (Figure 6). When cultured under chondrogenic conditions, the 
ASC formed nodules. Collagen type II mRNA expression 
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Figure 4. Effect of adipose tissue harvesting procedure on the frequency of cultured stromal vascular fraction cells (passage 1 or 2) exhibiting an 
ASC phenotype. Triple staining was peiformed using APC-labeled MAb against human CD34, FITC-labeled MAb against CD31 and PE-labeled 
MAb against CD105, CD166, CD45 and CD90. The CD34+ CD3r cell fraction was gated (a) and expression of CD105, CD166, CD45 and 
CD90 of the cells within gate 1 are shown in histogram plots (b). Data are from one culture, representative of all cultures. Each histogram plot 
contains an isotype-matched MAb control, indicated as a dashed line. (c) Frequencies of CD34+ CD31- CD105+ CD166 + CD45- CD90+ 
cells (expressed as mean± SEM) in the cultures, derived from stromal vascular fraction cells obtained by resection, tumescent liposuction or 
ultrasound-assisted liposuction. APC, allophycocyanin; ASC, adipose tissue-derived stem cell; Neg., negative. 
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Figure 5. Effect of the adipose tissue harvesting procedure on growth kinetics of ASC in vitro. Adipose tissue was harvested using resection, 
tumescent liposuction or ultrasound-assisted liposuction, and stromal vascular fraction cells were isolated. For each cell isolate, 10 T25 flasks seeded 
with 1 x 1(/ cells (passage 2 or 3) were prepared. After several days of culture, cells from two flasks were harvested and cell numbers counted. 
Numbers of ASC were plotted against the number of days in culture. (a) Growth kinetics of ASC of a representative donor when adipose tissue was 
harvested by resection. (b) Growth kinetics of ASC when adipose tissue was harvested by tumescent liposuction. (c) Growth kinetics of ASC when 
adipose tissue was harvested by ultrasound-assisted liposuction. ( d) Population doubling time was calculated from the logarithmic growing phase of 
the cells. The population doubling time of ASC obtained after ultrasound-assisted liposuction was calculated from all time points tested. A 
significant difference (P < 0.05; independent sample t-test) was detected in ASC doubling time between adipose tissue harvested using ultrasound­
assisted liposuction and by resection or tumescent liposuction. ASC, adipose tissue-derived stem cell; RS, resection; T-LS, tumescent liposuction; US­
LS, ultrasound-assisted liposuction. 
increased expression of osteopontin and collagen type I 
mRNA was detected within 7 days (Figure 6d). 
Discussion 
The purpose of the present study was to compare the yield 
and growth characteristics of ASC, which were isolated 
from adipose tissue harvested via three different types of 
surgical procedures, i.e. resection, tumescent liposuction 
and ultrasound-assisted liposuction. We found that adipose 
tissue obtained by resection or tumescent liposuction 
provides high frequencies of rapidly growing ASC, which 
could be used for tissue-engineering purposes, whereas 
adipose tissue obtained by ultrasound-assisted liposuction 
provides low amounts of ASC exhibiting low proliferative 
capacity. 
ASC have recently been tested in a number of in vitro 
models for treatment of human diseases [6,7,10-12,23]. In 
most of these studies, ASC were isolated from adipose 
tissue obtained via tumescent liposuction. However, in 
daily practice the adipose tissue is harvested via different 
surgical procedures and therefore we tested whether 
different surgical procedures affect yield and functional 
characteristics of the ASC. The number of viable cells 
harvested from adipose tissue was approximately 0. 7 x 106 
cells/g adipose tissue, which is similar to reported cell 
yields obtained from lipoaspirate [6,7,24]. We found that 
2
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Figure 6. Chondrogenic and osteogenic differentiation potential of cultured ASC. Passage 2 ASC were cultured in micromass in chondrogenic 
medium containing TGF-P 1 (a- c) and in a monolayer in osteogenic medium containing BMP-2 (d). (a) Cell nodules formed under chondrogenic 
culture conditions were harvested after 4 days and demonstrated expression of collagen type II mRNA, as analyzed by reverse transcription PCR. 
ASC cultured under standard culture conditions did not express collagen type II mRNA. Cell nodules harvested after 2 weeks were fixed in 
paraformaldehyde, embedded in paraffin, and sections were analyzed using (immuno)histochemistry. (b) Production of proteoglycans was detected in 
Alcian blue staining (magpification 100 x) and (c) production of collagen type II was detected using MAb II-II6B3 (magpification 400 x ). 
Control sections were incubated with PBS instead of MAb and did not show positive staining ( data not shown). ( d) ASC cultured under osteogenic 
conditions were harvested after 7 days and demonstrated osteopontin and Col Jal mRNA expression, as analyzed by real time PCR. Results are 
expressed as T / C ratio, where the control cells were cultured in osteogenic medium without BMP-2. ASC, adipose tissue-derived stem cell; BMP-2, 
bone morphogenetic protein 2; OPN, osteopontin; TGF-P 1, transforming growth foctor-P 1. 
the surgical procedure used, i.e. resection, tumescent 
liposuction and ultrasound-assisted liposuction, did not 
affect the yield of viable stromal vascular fraction cells 
obtained from adipose tissue. This is remarkable because 
high-intensity ultrasonic energy, as used in ultrasound­
assisted liposuction, or infiltration fluid, as used for 
harvesting adipose tissue in tumescent liposuction, could 
potentially damage the stromal vascular fraction cells, 
resulting in lower frequencies of viable cells. 
A series of Ab to surface epitopes of cultured MSC have 
been employed by several investigators [4,7,24-27]. Two of these surface markers, CD105 and CD166, have been 
used to define a BM stromal cell population defined as 
MSC [8]. Only recently, MSC from adipose tissue have 
been shown to be CD34 + . Boquest et al. [28] and
Miranville et al [29] isolated CD34 + CD31 - cells from
the SVF of adipose tissue, and they demonstrated that this 
cell population differentiated into the chondrogenic, 
osteogenic, adipogenic and neurogenic pathways, and 
into endothelial cells, respectively. We, and others, found that ASC show detectable but diminished levels of CD34 
expression after short culture periods of 3-14 days (data 
not shown) [30]. Therefore in the present study we used a 
co34 + CD31- co105+ CD166 + CD45-CD90 + 
marker profile to assess the frequency of ASC after 1-2 weeks of culture. After culture more than 80% of the cells 
exhibited an ASC phenotype, irrespective of the operative 
procedure used. Thus all three operative procedures 
resulted in homogeneous cultures of ASC that were used 
for the growth kinetic experiments. 
The results from the cell viability tests show that the 
three surgical procedures resulted in equal numbers of 
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SVF cells isolated. However, the surgical procedure used 
did affect tremendously the functional properties of the 
ASC. Ultrasound-assisted liposuction decreased the mean 
frequency of ASC in the stromal vascular fraction by 16-
fold compared with resection, and it increased the 
population doubling time of cultured ASC by more than 
10-fold. Cell cultures from ultrasound-assisted liposuction
material yielded limiting numbers of ASC, and therefore
differentiation experiments with these cells were not
performed. The differentiation potential of the ASC
from resection and tumescent liposuction material was
investigated by culturing the cells under chondrogenic and
osteogenic conditions. The results demonstrated that the
ASC were capable of differentiating both into the
chondrogenic and osteogenic pathways. Remarkable, but
as yet unexplained, is that the frequency of ASC in adipose
tissue far exceeds the MSC frequency in BM, which is only
0.01-0.001 % [8]. The mean population doubling time of
cultured ASC was similar when adipose tissue was
harvested using resection (2.6 days) and tumescent
liposuction (2.8 days). This population doubling time is
in agreement with that obtained by Zuk et al. [ 6] using
tumescent liposuction.
The infiltration of tissue with aqueous solution and 
irradiation with high-intensity ultrasonic energy, as prac­
ticed in ultrasound-assisted liposuction, can induce tran­
sient cavitation as observed in vitro, with the concomitant 
production of radicals and oxidizing reactants associated 
with a variety of high-energy chemical reactions and 
generation of light mainly in the UV spectrum [20,31-37]. 
Although these are probably the main mechanisms of 
interaction with tissue that may lead to long-term adverse 
effects, their combination with localized temperature 
elevation and mechanical stress, as is present during 
ultrasound-assisted liposuction, may substantially amplify 
their biologic effects. High-intensity ultrasonic energy 
may interact with tissue in a complex mechanism that may 
lead to immediate cell killing and/or apoptosis [36]. In the 
present study, ultrasound probably did not affect the 
membrane integrity because cell viability using trypan 
blue exclusion was not affected. So it is feasible that 
ultrasound causes late cell killing or apoptosis, or induc­
tion of irreparable DNA damage, resulting in decreased 
growth capacity. Based on this, ultrasound-assisted lipo­
suction is clearly not a suitable procedure for harvesting 
adipose tissue when ASC are to be used for tissue­
engineering purposes. 
Mechanical shearing forces resulting from tumescent 
liposuction may be expected to affect ASC viability. 
However, we did not observe a negative effect of 
tumescent liposuction on ASC function compared with 
resection, which uses the least chemicals and mechanical 
forces for harvesting the adipose tissue. The variations in 
ASC frequency observed with tumescent liposuction might 
have resulted from differences in handling the adipose 
tissue by the various surgeons. Several research groups, 
showing in vitro differentiation of adipose tissue stromal 
cells into the mesenchymal lineage, have demonstrated the 
multipotent potential of adipose tissue stromal cells 
isolated from adipose tissue obtained by tumescent 
liposuction [6,7,10]. It is likely that the potential of 
resection material is at least as good or even better than 
that obtained by tumescent liposuction, as mechanical 
forces resulting in shear stress are absent during resection. 
We were able to isolate stromal vascular fraction cells 
from all the anatomical sites tested, i.e. abdomen, hip/thigh 
region and mamma tissue, and we did not find significant 
differences in cell yield and viability. However, adipose 
tissue harvested from the breasts has a negative cosmetic 
side effect. Contamination with glandular cells may cause 
dramatic variations in cell counts, and it cannot be 
excluded that differentiated glandular cells affect ASC 
proliferation and differentiation. Adipose tissue from the 
abdomen or hip/thigh region is available in larger 
quantities, is easier to obtain, and causes minimal cosmetic 
disadvantages, which suggests that adipose tissue derived 
from both abdomen and hips harvested by resection or 
tumescent liposuction can be used for tissue-engineering 
purposes. 
We conclude that the yield and growth characteristics of 
ASC are affected by the type of surgical procedure used 
for adipose tissue harvesting. Lower ASC yields and 
growth capacities were observed with ultrasound-assisted 
liposuction material, and therefore resection and tumes­
cent liposuction seem to be preferable rather than 
ultrasound-assisted liposuction for tissue-engineering pur­
poses. These findings provide a general guideline for the 
optimal surgical technique as well as the optimal anato­
mical site for harvesting adipose tissue to isolate ASC for 
use in tissue engineering. As the frequencies of functional 
ASC in adipose tissue exceed those in the BM, adipose 
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layers, are embryonic stem cells (1). However, the on­
going intense ethical and political debate restricts their 
use. An alternative source is provided by adult, bone mar­
row-derived mesenchymal stem cells (MSCs), present 
within the bone marrow stroma. These bone marrow-de­
rived stromal cells have already demonstrated efficacy in 
multiple examples of cellular therapies (2-7). The re­
trieval of stem cells from the bone marrow, however, is 
highly invasive and provides only low numbers of stem 
cells. Therefore, alternative sources for MSCs have been 
investigated. 
Only recently, adipose tissue was defined as a new 
source of MSCs. Like the bone marrow, adipose tissue 
contains a stromal fraction, further referred to as stromal 
vascular fraction or SVF, which contains a population of 
adipose tissue-derived stem cells (ASCs) (8). An advan­
tage of using adipose tissue as the source of stem cells 
is that the harvesting of adipose tissue is minimally in­
vasive and can be done under local anesthesia, thus re­
sulting in minimal patient discomfort and low patient 
risk. Furthermore, adipose tissue provides large numbers 
of stem cells as compared to bone marrow. A bone mar­
row transplant of 100 ml contains approximately 6 X 108 
nucleated cells (9), of which only 0.001-0.01 % 
(0.006-0.06 X 106 cells) is a stem cell (10). In compar­
ison, the number of viable SVF cells that can be retrieved 
from subcutaneous fat is approximately 0.5-2.0 X 106 
cells/gram of adipose tissue (8,9,11,12), whereby the per­
centages of stem cells within the SVF range from 1 to 
10% (12-14), most likely depending on donor and tissue 
harvesting site. This implicates that approximately be­
tween 0.5 X 106 and 20 X 106 stem cells can be retrieved 
from 100 grams of fat, which is an amount that can eas­
ily be obtained from a patient. The ASCs have shown to 
be multipotent and have the capacity to differentiate into 
adipocytes, chondrocytes and osteoblasts (15), myocytes 
(16,17), neuronal cells (15,18,19), cardiomyocytes (20), 
and hepatocytes (21) in vitro. Therefore, ASCs may have 
the potential to be used for various clinical applications, 
including bone, cartilage, and cardiac repair. The stromal 
fraction of adipose tissue is a heterogeneous mixture of 
cells, including endothelial cells, smooth muscle cells, 
pericytes, fibroblasts, mast cells, and preadipocytes 
(8,22). The capacity of the ASCs to adhere to plastic and 
expand in vitro is generally used to select and expand the 
stem cells. The current practice of culturing cells is time 
consuming, expensive, and inefficient because it requires 
the incorporation of current Good Manufacturing Prac­
tice ( cGMP) to allow reinfusion into patients. Perhaps 
more importantly, culturing may affect the functional 
characteristics of the ASCs, such as their potential to 
home to the site of tissue damage (23) due to a change 
in the expression of adhesion molecules during culture. 
Such culture-expanded cell isolates, enriched for ASCs, 
may therefore become unsuitable for systemic infusion 
purposes. Culturing may also have an effect on the dif­
ferentiation potential of the ASCs; however, this has not 
been investigated yet. 
For clinical practice, it would be advantageous to use 
the SVF cells, because they can be harvested during the 
operative procedure itself and given back to the patient 
without the need for further in vitro expansion. Because 
adipose tissue is such an abundant source of stem cells, 
such an approach may be feasible. Most of our knowl­
edge of ASCs, however, is based on phenotypical and 
functional characterization of cultured ASCs (14-22, 
24-31). In this study, we investigated the phenotypical
and functional characteristics of freshly isolated ASCs in
the SVF of adipose tissue, as compared to cultured ASCs.
Whereas culture-expanded ASCs represent a rather ho­
mogeneous cell population (8,13,32-34), the SVF is a
heterogeneous mixture of cells. The immunophenotype
of the whole SVF fraction has been previously investi­
gated (13,33). However, to our knowledge, the ASCs in
the SVF have not been characterized yet. For analyzing
the phenotypical marker profile of freshly isolated ASCs,
the ASCs were identified in the SVF on the basis of their
high expression of CD34 and lack of expression of
platelet endothelial cell adhesion molecule (PECAM or
CD31) (24). Subsequently, the expression of stem cell
markers CDl 17, Flt3, and CD133, several cell adhesion
molecules, CD105 (endoglyn), HLA-ABC and HLA-DR,
common leukocyte antigen CD45, and melanoma cell ad­
hesion molecule CD146 on this cell population was in­
vestigated using three-color staining and flow cytometry.
The expression of these surface markers on freshly iso­
lated ASCs was compared to the expression on cultured
ASCs. Next, we investigated whether freshly isolated
ASCs in the SVF have functional properties comparable
to cultured ASCs. In this part of the study, we selected
for the ASCs in the SVF by seeding SVF cells in plastic
culture wells. We demonstrated by confocal microscopy
that more than 85% of the SVF cells that initially adhered
to the culture wells had a CD34 +co31-co45-cD146-
ASC-like phenotype. Differentiation of the freshly iso­
lated ASCs into the osteogenic pathway was investigated
and compared with that of cultured ASCs.
MATERIALS AND METHODS 
Tissue sampling 
Human subcutaneous adipose tissue samples were ob­
tained as waste material after elective surgery and do­
nated upon informed consent of the patients by the de­
partment of Plastic Surgery from the VU University 
Medical Center. Adipose tissue was harvested from the 
abdomen or hip and thigh region of healthy females, us­
ing either resection or tumescent liposuction. Eight fe-
3
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male donors (mean age 42; range 28-62 years) were in­cluded in this study. The mean body mass index was 26.3 ± 2.4 (mean ± SD). 
Isolation and culture of the SVF of adipose tissue 
Adipose tissue was weighed and extensively washed with phosphate-buffered saline (PBS). Resected material was first cut into small pieces using a surgical scalpel. Tissue was digested enzymatically with 0.1 % Collage­nase A (Roche Diagnostics GmbH, Mannheim, Ger­many) in PBS and 1 % bovine serum albumin (BSA), for 45 min at 37°C with intermittent shaking. Enzyme ac­tivity was then neutralized by adding Dulbecco's modi­fied Eagle's medium (DMEM) containing 4.5 g/L glu­cose (BioWhittaker, Cambrex, Verviers, Belgium) and supplemented with 10% fetal bovine serum (FBS). The digested adipose tissue (AT) was centrifuged for 10 min at 600 X g. The cell-containing pellet was resuspended in PBS and passed through a 200-µ,m nylon mesh (Braun/ Beldico s.a-n.v, Marche-en Famenne, Belgium) to re­move debris. Subsequently, cells were subjected to a Fi­coll density centrifugation step (p = 1,077 g/ml, osmo­larity 290 ± 15 mOsm; Axis-Shield, Oslo, Norway) to remove erythrocytes. The cell-containing interface was harvested and washed with DMEM and 10% FBS. Via­bility of the cells was assessed using the Trypan Blue ex­clusion assay. Viable, large cells with an irregular mor­phology were counted, using light microscopy. A total of 5 X 106 cells were resuspended in a mixture (1: 1) of DMEM and 10% FBS and cryoprotective medium (Freezing Medium, BioWhittaker, Cambrex, Verviers, Belgium), frozen under "controlled rate" conditions in a Kryosave (HCI Cryogenics BV., Redel, The Nether­lands), and stored in the vapor phase of liquid nitrogen according to standard practice in the Department of Pathology of the VU University Medical Center, and fol­lowing the guidelines of cGMP. Single-cell suspensions of SVF cells were seeded at 1 X 105 cells/cm2 in normal culture medium, consisting of DMEM supplemented with 10% FBS, 100 U/ml peni­cillin, 100 µ,g/ml streptomycin, and 2 mM L-glutamine (all from Gibco, Invitrogen, CA). The cultures were maintained in a 5% CO2 incubator at 37°C in a humidi­fied atmosphere. The medium was changed twice a week. When reaching 80-90% confluency, cells were detached with 0.5 mM EDTN0.05% trypsin (Gibco, Invitrogen, CA) for 5 min at 37°C and then replated. Cell viability was assessed using the Trypan Blue exclusion assay. 
Flow cytometry 
Single-cell suspensions of cryopreserved, freshly iso­lated adipose tissue-derived SVF cells and cultured pas­sage-4 ASCs were phenotypically characterized using 
fluorescence-activated cell sorting (FACS; FACSCal­ibur, Becton Dickinson, USA). Cells were washed in FACS buffer (PBS containing 1 % BSA and 0.05% so­dium azide) and 1 X 105 per sample cells were incubated on ice with the optimal dilution of conjugated monoclo­nal antibody (mAb) in F ACS buffer. All mAbs were of the immunoglobulin G1 (IgG 1) isotype. We used allo­phycocyanin (APC)-conjugated antibodies against CD34 (clone 8612) and CD45, both from BD Biosciences (San Jose, CA). Fluorescein isothiocyanate (FITC)-conjugated mAbs against CO2, CD3 and CD14 (all from BD), CD19, CDl lb (PharMingen, San Diego, Cal), activated leuko­cyte cell adhesion molecule (ALCAM or CD166, clone 3A6, RDI Research Diagnostics, Flanders, NJ), and PECAM (or CD31, BD) were used. Phycoerythrin (PE)­conjugated mAbs against c-kit (CDl 17, PharMingen, San Diego,CA), CD133 (clone 293C3,MiltenyiBiotec GmbH, Germany), Flt3 (Immunotech), endoglyn (CD105, clone SN6, Caltag Laboratories, Burlingame, CA), melanoma cell adhesion molecule (MELCAM or CD146, mAb 16985H, Chemicon Temecula, CA), Thy-1 (CD90, clone 5El 0, BD), HLA-DR, HLA-ABC, vascular cell adhesion molecule-I (VCAM-1 or CD106), and intercellular ad­hesion molecule-I (ICAM-1 or CD54) (all from BD) were used. After a 30-min incubation, cells were washed twice with FACS buffer. Nonspecific fluorescence was determined by incubating cells with conjugated mAb anti-human IgG1 (DAKO Cytomation, Glostrup, Den­mark). Flow cytometry data were analyzed using CELLQUEST software (Becton Dickinson). Of three donors, cell populations were sorted based on the levels of CD34 and CD31 expression, using FACSvantage™ (Becton Dickinson). Sorted cells were seeded at a den­sity of 104 cells/cm2 and expanded in vitro. 
Phenotypical characterization of SVF cells adhering to plastic culture wells 
A total of 40,000 SVF cells were seeded (n = 3) per Lab Tek® Chamber Slide of 1.9 cm2 (Nalge Nunc Int Corp, Naperville, IL). After 2 and 6 days of culture, cells were washed with PBS and fixed in 4% paraformalde­hyde for 30 min. Cells were then washed two times with PBS and once with PBS and 1 % BSA. Cells were incu­bated for 1 h with a 1 :50 dilution of mAbs against CD34, CD31, CD45 (all from BD Biosciences, San Jose, CA), and CD146 (Chemicon Temecula, CA) in PBS and 1 % BSA. Cells were then washed three times with PBS and 1 % BSA and incubated with a 1:500 dilution of biotin­conjugated rabbit antibodies against mouse im­munoglobulins RaMBioF(ab'h (DAKO Cytomation, Glostrup, Denmark) in PBS and 1 % BSA for 1 h. After three washings with PBS, a 1 :500 dilution of Streptavidin Alexa Fluor™ 488 conjugate (Molecular Probes, Eugene, OR) was added for 1 h. Cells were washed three times 
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with PBS and nuclei were stained with 7.5 µ.M propid­ium iodide (Pl) during 15 min. After washing three times with PBS, cells were covered with Vectashield mounting medium (Vector Laboratories, Inc. Burlingame, CA). An­tibody staining of the cells was analyzed by confocal mi­croscopy, using a Leica TCS SP5 (Leica Microsystems, Wetzlar, Germany). The percentage of adhering cells that stained positive for CD34, CD31, CD146, and CD45, re­spectively, was quantified by previously developed im­age analysis software (35). 
Osteogenic differentiation of SVF cells and 
cultured ASCs 
For osteogenic differentiation, SVF cells were seeded at 50,000 cells/cm2 and cultured ASCs (passage 4) at 5,000 cells/cm2• Because the SVF isolates are heteroge­neous mixtures of cells, the contribution of stem cells in these isolates is relatively low and ranges between ap­proximately 1 and 10% (12-14). In contrast, after four passages in culture, the ASCs form a homogeneous pop­ulation of cells regarding their surface marker expression and probably do contain almost exclusively stem cells (9,11,27). To add similar numbers of stem cells to the culture wells, SVF cells were plated at 10-fold higher densities than cultured ASCs. Cells were cultured in monolayer in osteogenic medium, consisting of normal culture medium supplemented with 10 mM ,8-glycerol phosphate, 50 µ.g/ml ascorbate-2-phosphate, and 100 ng/ml bone morphogenetic protein-2 (BMP-2; Peprotech EC LTD, London, UK). Control cells were cultured in normal culture medium. Osteogenic and control media were changed twice a week. BMP-2 has been shown to induce osteogenic differentiation both in cultured bone marrow-derived MSCs and cultured ASCs, in vivo and in vitro (36-39). 
Reverse transcription PCR 
Osteogenic gene expression by SVF cells (n = 4) was analyzed by measuring Runx-2, osteopontin, and Collagen 
type l mRNA(4�2) after 7, 10, and 12 days ofosteogenic stimulation using RT-PCR. Total RNA from the cells was isolated using TRlzol® reagent (lnvitrogen, Carlsbad, CA).cDNA synthesis (GeneAmp® PCR System9700, PE Ap­plied Biosystems, CA) was performed using 0.5-1 µ.g of total RNA in a 20-µ.l reaction mix containing 5 Units of Transcriptor Reverse Transcriptase (Roche Diagnostics), 0.08 A260 units random primers (Roche Diagnostics), and 1 mM of each dNTP (Invitrogen). The cDNA was stored at -80°C prior to real-time PCR.Real-time PCR reactions were performed using the SYBRGreen reaction kit according to the manufacturer's instructions (Roche Diagnostics) in a LightCycler (Roche Diagnostics). Primers (Invitrogen) used for real-time PCR are listed in Table 1. For real-time PCR, the values of relative target gene expression were normalized for relative 18S housekeeping gene expression. 
Alkaline phosphatase activity 
To assess the osteoblastic phenotype of the osteogenic stimulated SVF cells (n = 4), alkaline phosphatase (ALP) activity was measured after 14 days of culture in osteogenic medium or control medium. ALP activity and protein content were determined in the cell lysate. As substrate, p-nitrophenyl phosphate (Merck) at pH 10.3 was used to determine ALP activity. The absorbance was read at 410 nm. ALP activity data were expressed as mil­limole per microgram of protein in the cell layer. The amount of protein was determined using a BCA Protein Assay Reagent kit (Pierce, Rockford, IL), and the ab­sorbance was read at 570 nm with a microplate reader (BioRad Laboratories Inc., Hercules, CA). 
Von Kossa staining 
To assess matrix mineralization in cultures of freshly isolated ASCs, SVF cells (n = 3) were cultured for 21 days in either osteogenic medium or control medium. Then wells were rinsed with PBS and fixed in 4% para­formaldehyde for 1 h. Cells were then rinsed with dis-
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tilled water and overlaid with a 5% silver nitrate solution in the dark for 30 min, followed by rinsing with destilled water. After exposure to ultraviolet light for 1 h, cells were treated with sodium thiosulfate for 5 min and rinsed with distilled water. Finally, cells were counterstained us­ing Fast Green. Calcified extracellular matrix was de­tected as black spots. 
lmmunohistochemistry 
SVF cells (n = 4) were seeded at 50,000 cells/cm2 in Lab Tek Chamber slides, and cultured in osteogenic 
A B 
medium. After 7 and 14 days of culture, cells were washed with PBS and fixed in 4% paraformaldehyde for 30 min. Cells were then washed two times with PBS and once with PBS, 1 % BSA, and 0.1 % saponin. Cells were incubated for 2 h with a 1 :50 dilution of rabbit antibod­ies against osteonectin (EMD Biosciences, Inc., La Jolla, CA) in PBS, 1 % BSA, and 0.1 % saponin. Cells were then washed three times with PBS, 0.1 % BSA, and 0.1 % saponin and incubated with a 1:200 dilution of biotin­conjugated goat antibodies against rabbit immunoglobu­lins (BD Biosciences Pharmingen, San Diego, CA), in PBS, 1 % BSA, and 0.1 % saponin for 1 h. After three 
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FIG. 1. Identification of ASC population in the SVF of adipose tissue. Freshly isolated SVF cells were stained with APC­labeled mAb anti-CD34, FITC-labeled mAb anti-CD31, and PE-labeled mAb anti-CD 146. (A) Populations of cells defined by gates Rl, R2, R3, and R4 were isolated by FACS. (B) Staining of isotype-matched control mAbs. (C) Sorted cells of gate Rl were analyzed for CD34, CD31, and CD146 expression. Data are from one isolate and representative of analyses of 3 donors. (D,E) CD34, CD105, and CD166 expression of Rl cells (defined in Fig. lA) after 1 week of culture (passage 1). (F) Staining of isotype-matched control mAbs. (G) Double staining of SVF cells with FITC-labeled mAb against CD34 and APC-labeled mAb against CD45. Data are from one isolate and representative of analyses of 3 donors. Abbreviations: APC, allophycocyanin; ASC, adipose tissue-derived stem cell; PE, phycoerythrin; SVF, stromal vascular fraction. 
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washings with PBS, a 1:500 dilution of Streptavidin Alexa Fluor™ 488 conjugate was added for 1 h. Cells were washed three times with PBS, and nuclei were stained with 7.5 µ.M PI for 15 min. After washing three times with PBS, cells were covered with Vectashield mounting medium. Antibody staining of the cells was an­alyzed by confocal microscopy, as described above. 
Statistics 
Increased gene expression and ALP activity were an­alyzed using a one-tailed, paired Student's t-test. 
RESULTS 
ASCs are present in the CDJ4bright CDJ J- cell 
fraction of the SVF of adipose tissue 
First we verified that the co34+co31- fraction of SVF cells contained the ASCs, as previously demon-
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FIG. 2. Phenotypical characterization of ASC-containing cell fraction in the SVF of adipose tissue using flow cytometry. (A) FSC/SSC disribution of all cells. (B) Staining of isotype-matched control mAbs. (C) Triple stainings of SVF cells with APC­labeled mAb anti-CD34, FITC-labeled mAb anti-CD31, and each of the indicated mAbs, labeled with PE. The CD34brightcD31-cell fraction was gated (gate Rl) and the histogram plots of the cells within Rl are shown in D-L. Data are from one isolate and representative of analyses of 5 individuals. Each histogram plot contains an isotype-matched mAb control, which is indicated as a dashed line. Abbreviations: APC, allophycocyanin; ASC, adipose tissue-derived stem cell; SVF, stromal vascular fraction. 
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CD34 - cells, but is caused by a decrease in CD34 ex- Differences in su,face marker expression between pression of the ASCs. Cultured cells were also positive freshly isolated ASCs and cultured ASCs for CD105 and CD166 (Fig. lE). 
Phenotypical characterization of freshly 
isolated ASCs 








iso CD105 CD166 CD146 HLA-DR 
To compare the surface marker expression of freshly isolated ASCs with that of cultured ASCs, cultured ASCs from 3 donors (passage 4) were characterized phenotyp­ically using flow cytometry (Table 2). Cultured ASCs demonstrated to be a homogeneous population of cells in surface marker expression showed an increased expres­sion of CD 105 and CD 166, as compared to the ASCs in fresh cell isolates. On the other hand, CD34 expression on the cultured ASCs was diminished dramatically and HLA-DR and CDll 7 expression was lost. 
Identification of other cell populations within the 
SVF of adipose tissue 














CD117 CD106 CD34 CD90 
FIG. 3. Phenotypical characterization of the ASC-containing cell fraction in the slromal vascular fraction of adipose tissue, us­ing flow cytometry. Freshly isolated SVF cells of 4 donors were analyzed in three-color stainings using APC-labeled mAb anti­CD34, FlTC-labeled mAb anti-CD31, and each of the indicated mAbs, labeled with PE. The CD34brigh1CD31- cell fraction was gated (as in Fig. 2C, gate Rl) and staining results of the PE-labeled mAbs are expressed as the mean fluorescence ( +SD). Note the different y axis scales. Abbreviations: APC, allophycocyanin; ASC, adipose tissue-derived stem cell; MF, mean fluorescence intensity; SVF, stromal vascular fraction. 
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TABLE 2. SURFACE MARKER EXPRESSION ON FRESHLY lsoLATED AND CULTURED ASCs 
Cell-surface marker 
Freshly isolated 
ASCs (n = 5) Cultured ASCs passage 4 (n = 3) 
CD34 CD166 CD105 CD90 HLA-ABC HLA-DR 
CD45 CD117 Flt3 CD133 CD106 CD54 
MF isotype control < 4.25 
+++ +!­+ +++ ++ + 
+ 
++ 
-, MF< 8.50; +!-, 8.5 <MF< 9; +, 10 <MF< 100; ++, 100 <MF< 1,000; +++, MF> 1,000. Abbreviations: Mean fluorescence intensity, MF. 
+ + ++ +++ ++ 
++ 
TABLE 3. FREQUENCY OF CELL POPULATIONS IN 1HE S1ROMAL VASCULAR FRACTION OF ADIPOSE TISSUE 
Frequency (%) 
Phenotype (n = 5) Cell type 
CD34brigh1CD31-CD146- 34.6 ±: 17.8 ASC-like cn34hrighicn31 +cn146+ 12.2 ±: 9.5 Endothelial cell cn34dirnCD31-CD146+ 10.3 ± 9.9 Vascular smooth muscle celVpericyte CD45+cn34- 14.2 ±: 2.3 Leukocyte CD45+cn34+ 5.2 ±: 1.3 HSC-like cn45+cn34+cm11+ 0.75 ±: 0.1 HSC-like CD45+cn34+cm33+ 0.02 ±: 0.03 HSC-like CD45+cn34-cn3+ 4.8 ±: 1.9 T cell CD45+cn34-cm9+ 0.2 ±: 0.3 B cell CD45+cn34-cm11+ 0.56 ±: 0.2 Mast cell cn45+cn11b+ 6.1 ±: 3.2 Granulocyte cn45+cm4+ 5.2 ±: 4.3 Monocyte 
Cell populations in the stromal vascular fraction of 5 donors were phenotypically characterized in riple stainings, using flow cytometry. Results are expressed as mean±: SD. Abbreviations: HSC, hematopoietic stem cell; ASC, adipose tissue-derived stem cell. 
COLOR PLATE 2. Osteogenic differentiation of freshly isolated ASCs and cultured ASCs. SVF cells and passage-4 ASCs were cultured in osteogenic medium (containing 10 mM ,8-glycerol phosphate, 50 µg/ml ascorbic acid, and 100 ng/ml BMP-2), and in normal culture medium, respectively. (A) After 14 days of culture, ALP activity and protein content were determined in the cell lysates of SVF cultures (n = 4) and ASC cultures (n = 8). (B) After 14 days of culture, cells were fixed and stained with rabbit antibodies against human osteonectin. mAb binding was detected by subsequent stainings with biotin-conjugated goat an­tibodies against rabbit immunoglobulins and Streptavidin Alexa Fluor™ 488 conjugate, followed by confocal Inicroscopy (mag­nification, 400X). Positive staining was not detected when PBS was used instead of the primary antibody (not shown). (C) Ma­trix Inineralization was detected after 21 days in von Kossa staining. Positive staining was not detected when SVF cells were cultured in normal culture medium (not shown). Abbreviations: ASC, adipose tissue-derived stem cell; BMP-2, bone morpho­genetic protein 2; SVF, stromal vascular fraction. 
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FIG. 4. Osteogenic gene expression of freshly isolated ASCs and cultured AS Cs. SVF cells (A,B,C, n = 4) and passage 4 AS Cs (D, n = 4) were cultured in osteogenic medium containing 10 mM /3-glycerol phosphate, 50 µ.g/ml ascorbic acid, and 100 ng/ml BMP-2. After 7, 10, and 12 days of culture, cells were harvested and total RNA was isolated. Runx-2, osteopontin, and Colla/ mRNA expression was analyzed using real-time PCR (see Table 1 for primer sets used), and related to 18S housekeeping gene expression. Abbreviations: ASC, adipose tissue-derived stem cell; BMP-2, bone morphogenetic protein 2; OPN, osteopontin; SVF, stromal vascular fraction. 
cells showed a large variation between the donors tested, ranging from 2.6% to 30% (10.3% ± 9.9%, mean ± SD, 
n = 5), and possibly represented vascular smooth mus­cle cells (VSMCs) and pericytes. To identify leukocyte populations in the SVF, freshly isolated SVF cells were also stained with a combination of CD34 and CD45, the common leukocyte antigen. Of the SVF cells, 55.3% ± 5.7% stained positive for CD34 and negative for CD45 (Fig. lG, R3). About 5.2% ± 1.3% of the cells showed expression of both CD34 and CD45, which is indicative for the presence of progenitor cells ofhematopoietic origin (Fig. lG, R2). Three-color stainings of the SVF cells for CD34, CD45, and a third surface marker specific for different types of leukocytes, identified additional populations of leucocytes. Within the co34+co45+ fraction also a co117+ cell popula­tion (0.75% ± 0.1%) was detected. A summary of the frequencies of the cell populations detected in the SVF of adipose tissue is listed in Table 3. 
Identification of cell populations in the SVF 
adhering to plastic culture wells 
When SVF cells are seeded in plastic culture wells, all cell populations in the SVF may potentially adhere, whereas 
we were only interested in the ASCs in the SVF. To study the conribution of freshly isolated ASCs and other cell pop­ulations initially binding to the culture wells, SVF cells were seeded and the adhering cell populaw.ons were identified, using confocal microscopy (Color Plate lA). Percentages of adhering cell populations were quantified (Color Plate lB). At day 2 after seeding 94% ± 2.4% of the adhering cells were CD34 +. Most CD34 + cells had s.-etched out and showed slender protrusions (Color Plate lA). Only low fre­quencies of CD31 + cells, co45+ cells and CD146+ cells were detected. After 6 days of culture, CD34 staining of the adhering cells had diminished dramatically in all 3 donors (Color Plate lB). Only low frequencies of CD31 + cells, co45+ cells CD146+ cells were detected. 
Osteogenic differentiation of freshly isolated and 
cultured ASCs 
The capability of freshly isolated ASCs to differenti­ate into the osteogenic pathway was investigated by cul­turing SVF cells in osteogenic medium containing BMP-2. The Runx-2, osteopontin, and Coll al mRNA ex­pression increased in time in all 4 donors tested. How­ever, the kinetics of gene expression varied between the donors with a peak expression between days 7 and 12. 
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To calculate the increase in gene expression, the peak ex­pression was taken in each donor. After osteogenic stim­ulation, both Runx-2 and Colla/ gene expression were significantly increased (Fig. 4A,B; p < 0.05). Osteopon­tin gene expression was also increased; however, this in­crease was not statistically significant (Fig. 4C). Runx-2gene expression in cultured passage-4 ASCs was signif­icantly increased at day 7 of osteogenic stimulation (Fig. 4D; p = 0.017). In previous studies, we already demon­strated an increased osteopontin and Colla/ mRNA ex­pression in cultured ASCs within 7 days of osteogenic stimulation (12). Freshly isolated ASCs showed increased ALP activity after 14 days of culture in osteogenic medium, as com­pared to cells cultured in normal culture medium (Color Plate 2A; p = 0.032). There was no significant difference 
in ALP activity between freshly isolated and cultured ASCs (p = 0.094). Osteonectin was detected in the cells after 7 days of osteogenic stimulation and intensity of staining increased in time (Color Plate 2B, 14 days). Ma­trix mineralization in the SVF cultures was demonstrated after 21 days (Color Plate 2C). 
DISCUSSION 
Regenerative cell-based therapies require an abundant source of adult stem cells that is readily available, prefer­ably at the time of operation. The SVF fraction of adipose tissue is such an abundant source of adult stem cells. Al­though cultured ASCs have been characterized exten­sively, only little is known about the phenotypical and functional characteristics of the freshly isolated stem cells 
in the SVF. In this study, we demonsk"ated that freshly iso­lated ASCs in the SVF slightly differed in immunopheno­type from cultured ASCs. In addition, we showed that, like cultured ASCs, freshly isolated ASCs were capable of dif­ferentiating into the osteogenic pathway. 
In this study, we first investigated the expression of cell-surface markers of freshly isolated ASCs in more de­tail and compared the phenotypical marker profile with that of cultured ASCs. Contrary to cultured ASCs, freshly isolated ASCs were highly positive for CD34, positive for CD117 and HLA-DR, and expression ofCD105 and especially CD166 was relatively low. Whereas the freshly isolated stem cells within the SVF express high levels of CD34, this expression of CD34 was lost upon culturing the cells, as was demonstrated in the FACS sort experi­ments and by confocal microscopy. Nevertheless, we show that this loss in CD34 expression did not imply a change in osteogenic differentiation capacity. Up to now, the phenotype of MS Cs in fresh cell isolates was not com­pletely clear, because of the low frequency of MSCs in the tissues from which they are retrieved. In the bone marrow, for example, MSCs represent only 0.001--0.01 % 
of the total population of cells (10). In most studies, the capacity of the cells to adhere to plastic and expand in vitro was used to select for MSCs, and the phenotypical characterization was performed on these culture-ex­panded cells. Because the frequency of stem cells in adi­pose tissue is much higher, it is possible to isolate and phenotypically characterize these ASCs directly ex vivo. Only recently, ASCs from adipose tissue have been dem­onstrated to be CD34 + (24,25,33). However, endothelial cells in the SVF are also CD34 +. These endothelial cells can be separated from the ASCs because they also express platelet endothelial cell adhesion molecule PECAM-1 or CD31. Hence, endothelial cells are CD34 +cD31 +, whereas AS Cs are CD34 +cD31 -. Bo­quest et al. (24) and Miranville et al. (25) isolated these CD34 +cD31 - cells from the SVF of adipose tissue and demonstrated that this cell population could differentiate into the chondrogenic, osteogenic, adipogenic, and neu­rogenic pathways, and into endothelial cells, respectively. 
In this study, we first phenotypically characterized the CD34 +cD31 - cell population in more detail in three­color stainings, using flow cytometry. The CD34brightCD31- cell fraction demonstrated a homogeneous ex­pression of the different surface markers. In contrast to the study of Boquest et al., we did detect CD117 and HLA-DR on the freshly isolated ASCs, although the ex­pression level of HLA-DR was low (MF = 32,9 ± 10; mean± SD, n = 4) as compared to that on CD34+ CD31 +cD146+ endothelial cells (MF= 1,750 ± 957; 
n = 4; data not shown). Our findings, however, are in agreement with studies ofMangi et al. (43), who showed CD117 expression on CD117+CD90+ MSCs from the rat's bone marrow, of Prunet-Marcassus et al. (44), who identified CD45-cD111+ immature cells in the SVF of mice adipose tissue, and of Beltrami et al. (45), who re­ported the existence of CDl 17+ multipotent stem cells in the heart, giving rise to myocytes, smooth muscle, and endothelial cells, thus demonstrating that CD 117 is more widely distributed on progenitor/stem cells. In addition, HLA-DR expression on bone marrow-derived MSC lines was previously reported by Ishii et al. (46). The expres­sion of HLA-DR might result in a rejection of the freshly isolated ASCs when used for cell-based therapies in an allogenic donor. However, in a pilot study, we did not detect proliferation of allogenic T cells induced by a FACS-sorted CD34brightcD31- cell fraction (data not shown). In this study, freshly isolated and cultured ASCs showed expression of CD54 (lCAM-1 ), whereas no CD106 (VCAM-1) expression was detected. This ex­pression pattern of CD54 and CD 106 is reversed as com­pared to bone marrow-derived MSCs (9,26), indicating that there are differences between ASCs and bone mar­row-derived MSCs. Next we investigated whether the freshly isolated ASCs in the SVF had comparable functional properties 
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as cultured ASCs. However, the SVF of adipose tissue is a heterogeneous mixture of cells, and when SVF cells are seeded in plastic culture wells all these cell populations may potentially adhere. We were only interested in the ASC fraction of the SVF. In the study using confocal mi­croscopy, we demonstrated that more than 85% of the SVF cells that initially adhered to the culture wells had an ASC-like phenotype, whereas only few endothelial cells, leukocytes, vascular smooth muscle cells, and peri­cytes adhered. To answer the question of whether the freshly isolated ASCs were capable of differentiating into the osteogenic pathway, SVF cells were cultured in osteogenic medium containing BMP-2. After osteogenic stimulation, gene expression of Runx-2, osteopontin, and Collagen type I in the freshly isolated ASCs was increased, although the increase in osteopontin gene expression was not statisti­cally significant. This was probably caused by the large differences in the amount of osteopontin mRNA pro­duced between the SVF isolates tested. Freshly isolated ASCs showed increased ALP activity, stained positive for osteonectin, and showed matrix mineralization, demonstrating the potential to differentiate into an os­teoblastic phenotype. The osteonectin response was de­tected throughout most of the cytoplasma, which is com­parable to osteonectin staining in bone cells (47). Although we did find some differences in the kinetics of osteogenic gene expression between the different SVF isolates and between freshly isolated and cultured ASCs, we show that the SVF represents an abundant source of freshly isolated ASCs, capable of differentiating into the osteogenic pathway in vitro. However, to use the freshly isolated SVF cells for clinical application, differentiation of the SVF cells into the osteogenic pathway is required without in vitro expansion and selection steps. To achieve this, a possible scenario would be to stimulate the freshly isolated SVF cells with BMP-2 in suspension for a brief period of only 15 min, just prior to transplantation. Such a short stimulus is shown to be sufficient to induce the differentiation of freshly isolated ASCs into the os­teogenic pathway (48). In addition, the biophysical and biochemical environment in vivo, which is provided by the scaffold and the surrounding tissue, may further in­duce or enhance the differentiation of the cells (49). In conclusion, we phenotypically characterized freshly isolated ASCs in the SVF and demonstrated that freshly isolated ASCs slightly differed in immunophenotype from cultured ASCs. In addition, we demonstrated that the freshly isolated ASCs in the SVF were capable of dif­ferentiating into the osteogenic pathway. As such, the use of freshly isolated ASCs for tissue engineering purposes involving bone repair is potentially applicable, and may have the advantage over cultured ASCs in the way that the SVF cells are readily available, and thus no costly expansion or isolation steps of the stem cells is required. 
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Abstract The stromal vascular fraction (SVF) of adipose 
tissue contains an abundant population of multipotent 
adipose-tissue-derived stem cells (ASCs) that possess the 
capacity to differentiate into cells of the mesodermal lineage 
in vitro. For cell-based therapies, an advantageous approach 
would be to harvest these SVF cells and give them back to 
the patient within a single surgical procedure, thereby 
avoiding lengthy and costly in vitro culturing steps. 
However, this requires SVF-isolates to contain sufficient 
ASCs capable of differentiating into the desired cell lineage. 
We have investigated whether the yield and function of 
ASCs are affected by the anatomical sites most frequently 
used for harvesting adipose tissue: the abdomen and hip/ 
thigh region. The frequency of ASCs in the SVF of adipose 
tissue from the abdomen and hip/thigh region was deter-
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mined in limiting dilution and colony-forming unit (CFU) 
assays. The capacity of these ASCs to differentiate into the 
chondrogenic and osteogenic pathways was investigated by 
quantitative real-time polymerase chain reaction and 
(immuno )histochemistry. A significant difference (P=0.0009) 
was seen in ASC frequency but not in the absolute number of 
nucleated cells between adipose tissue harvested from the 
abdomen (5.1 ± 1.1 %, mean±SEM) and hip/thigh region 
(1.2±0.7%). However, within the CFUs derived from both 
tissues, the frequency of CFUs having osteogenic differenti­
ation potential was the same. When cultured, homogeneous 
cell populations were obtained with similar growth kinetics 
and phenotype. No differences were detected in differentia­
tion capacity between ASCs from both tissue-harvesting sites. 
We conclude that the yield of ASCs, but not the total amount 
of nucleated cells per volume or the ASC proliferation and 
differentiation capacities, are dependent on the tissue­
harvesting site. The abdomen seems to be preferable to the 
hip/thigh region for harvesting adipose tissue, in particular 
when considering SVF cells for stem-cell-based therapies in 
one-step surgical procedures for skeletal tissue engineering. 
Keywords Adipose-tissue-derived stem cells • 
Chondrogenic differentiation • Osteogenic differentiation • 
Colony-forming unit assay• Stem-cell yield• 
Tissue-harvesting site • Human 
Introduction 
Tissue engineering is an emerging field in modern medicine. 
Therapies involve the combination of cells and scaffold 
materials that can be loaded with bioactive factors, ideally 
resulting in the regeneration or replacement of lost or 
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damaged tissues and organs. Multiple cell sources have been investigated for their possible applicability in tissue engineer­ing. Embryonal stem cells are the most potent stem cells; however, their use is controversial and has mayor ethical considerations (Dresser 2001). Mesenchymal stem cells (MSCs) can be obtained from the adult and are widely used because of their differentiation potential. In addition to bone marrow, periosteum (Nakahara et al. 1991), muscle (Asakura et al. 2001), and adipose tissue (Zuk et al. 2002) also appear to be sources of MSCs. Subcutaneous adipose tissue is a particularly attractive reservoir of progenitor cells, because it is easily accessible, abundant, and self-replenishing. It is derived from the mesodermal germ layer and contains a supportive stromal vascular fraction (SVF) that can be readily isolated (Gronthos et al. 2003; Zuk et al. 2001). This SVF from adipose tissue consists of a heterogeneous mixture of cells, including endothelial cells, smooth muscle cells, pericytes, leukocytes, mast cells, and pre-adipocytes (Oedayrajsingh­Varma et al. 2006; Peterson et al. 2005; Prunet-Marcassus et al. 2005). In addition to these cells, the SVF contains an abundant population of multipotent adipose-tissue-derived stem cells (ASCs) that possess the capacity to differentiate into cells of mesodermal origin in vitro, e.g., adipocytes, chondrocytes, osteoblasts, and (cardio)myocytes (Erickson et al. 2002; Guilak et al. 2004; Halvorsen et al. 2001; Hattori et al. 2004; Planat-Benard et al. 2004; Rangappa et al. 2003; Zuk et al. 2001). Because of these favorable characteristics, interest has been growing in the application of ASCs for cell-based therapies such as tissue engineering. For clinical practice, an advantageous approach would be to harvest ASCs and immediately give them back to the patient within the same operation, the so called "one-step surgical procedure" (Helder et al. 2007). This overcomes long-lasting culture expansion of ASCs on the one hand, but necessitates the use of the SVF of adipose tissue on the other hand, since fast selection procedures for stem cells in the SVF are not yet available. Therefore, the success of this procedure requires SVF-isolates to contain sufficient ASCs capable of differentiating into the desired cell lineage. In view of this, we have previously investigated the effect of three different surgical procedures for the harvesting of adipose tissue, i.e., resection, tumescent or conventional liposuction, and ultrasound-assisted liposuction, on the yield and function of the stem cells. We have demonstrated that the SVF isolates from adipose tissue harvested by ultrasound-assisted liposuction contain fewer stem cells, and that the stem cells have a longer population doubling time, leading us to conclude that resection and tumescent liposuction are preferable to ultrasound-assisted liposuction for harvesting adipose tissue, if the cells are to be used for tissue-engineering putposes (Oedayrajsingh-Varma et al. 2006). 
In the present study, we have investigated whether the yield and functional characteristics of ASCs in the SVF are affected by the most frequently used adipose­tissue-harvesting sites. We have previously demonstrated that the yield of nucleated cells in the SVF of the adipose tissue from these different tissue-harvesting sites is similar (Oedayrajsingh-Varma et al. 2006). In the current study, the frequency of ASCs in the SVF cell isolates has been determined by using limiting dilution and colony-forming unit (CFU) assays. In addition, we have investigated the frequency of CFU s showing an osteogenic differentiation capacity. SVF cells have been subsequently cultured in order to obtain homogeneous cell populations and to acquire sufficient cells to determine their chondrogenic differentiation potential in micromass cultures. Homoge­neity has been checked by determining the growth kinetics and phenotypic characteristics of the ASCs. To verify the maintenance of multidifferentiation potential, osteogenic and chondrogenic induction has been assessed in these homogeneous ASC cultures. 
Materials and methods 
Donors 
Samples of human subcutaneous adipose tissue were obtained as waste material after elective tumescent liposuc­tion or resection and donated after informed consent from healthy donors operated on at the Departments of Plastic Surgery of two clinics in Amsterdam, The Netherlands. Adipose tissue was taken from the abdomen (n=l2) and the hip/thigh region (n=l0) during cosmetic surgery; 22 female donors were included in this study. The average age (mean age 40, range 2�2 years) and body mass index (BMI; mean BMI 25.5; range 22.2-29.6 kg/m2) were similar forboth groups (Table l ). 
Cell isolation and storage 
Isolation of the SVF from adipose tissue was performed as previously described (Oedayrajsingh-Varma et al. 2006). The isolation protocol included a Ficoll density centrifugation step to remove contaminating erythrocytes. After isolation, 4xl06 SVF cells were resuspended in a mixture (1:1) ofDulbecco's modified Eagle's medium (DMEM) and cryo­protective medium (Freezing Medium, Bio Whittaker, Cam­brex, Verviers, Belgium), frozen under "controlled rate" conditions in a Kryosave (HCI Cryogenics, Redel, The Netherlands), and stored in the vapor phase ofliquid nitrogen according to standard practice at the Department of Pathol­ogy of the VU University Medical Center and following the guidelines of current Good Manufacturing Practice. 
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Table 1 Population characteristics (BMI body mass index, THS tissue-harvesting site, ASC adipose-derived stem cell, Res resection, T-LS tumescent liposuction, ND not determined) 
Donor Age (years) BMI (kg/m2) 
1 02-0001 62 22.6 2 03-0007 26 24.4 3 03-0018 42 23.9 4 03-0021 57 29.6 
5 04-0003 37 ND 6 04-0013 36 28.1 7 04-0015 37 26.9 8 05-0004 39 ND 9 05-0007 42 28.3 10 06-0003 50 26.5 
11 06-0006 42 24.2 12 06-0007 46 30.5 13 03-0010 24 24.4 14 04-0004 40 ND 15 04-0008 27 26.6 16 04-0009 36 ND 17 05-0005 34 22.2 18 05-0006 28 23.2 19 05-0008 43 24.6 20 06-0005 33 23.2 21 06-0010 52 26.2 22 06-0012 42 23.7 
Limiting dilution assay 
To assess the frequency of ASCs in the SVF of adipose tissue, SVF cells were seeded in normal culture medium, consisting of DMEM supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin, 100 µg/ml streptomycin, and 2 mM L-glutamine (Invitrogen, Gibco, Calif., USA) in 96-well plates at 15xI03 cells/well in the upper row. Two­fold dilution steps of the cells were made in subsequentrows. All cultures were performed in duplicate. Mediumwas changed twice a week. After 3 weeks, each well wasindividually scored for the number of cells. A wellcontaining a cluster of at least 10 adhered fibroblast-likecells was considered as being positive. The frequency ofASCs was calculated from the rows of cells for which25%-7 5% of the wells were scored as positive.
CFU assays 
CFU assays were performed to check the consistency of the limiting dilution assay method and to determine the frequency of CFU capable of differentiating into the osteogenic lineage from the abdomen (n=7) and hip/thigh region (n=6). SVF cells were resuspended in normal culture medium, consisting of DMEM supplemented with 10% FBS, 100 U/ml penicillin, 100 µg/ml streptomycin, and 
THS Procedure ASC yield (%) 
Abdomen Res 9.20 Abdomen T-LS 8.50 Abdomen Res 12.50 Abdomen Res 4.40 Abdomen T-LS 2.20 Abdomen Res 2.20 Abdomen Res 0.93 Abdomen T-LS 1.50 Abdomen T-LS 8.30 Abdomen T-LS 3.6 Abdomen T-LS 4.8 Abdomen T-LS 9.7 Hip/thigh T-LS 0.30 Hip/thigh T-LS 0.82 Hip/thigh T-LS 0.16 Hip/thigh T-LS 0.16 Hip/thigh T-LS 0.60 Hip/thigh T-LS 0.21 Hip/thigh T-LS 7.20 Hip/thigh T-LS 0.10 Hip/thigh T-LS 2.70 Hip/thigh T-LS 0.16 
2 mM L-glutamine (lnvitrogen, Gibco ). Two 6-well plates were prepared in which the SVF was diluted ten-fold across both columns, resulting in a upper column containing 104 and a lower column containing 103 nucleated SVF cells. For the CPU-fibroblast (CFU-F) assay, the fixation time was 11-14 days, depending on the amount and growth kinetics of the colonies (merging of colonies was avoided). At the appropriate time point, the medium was removed, and the cells were washed with phosphate-buffered saline (PBS), fixed with 4% formaldehyde for 10 min, and subsequently colored in a 0.2% toluidine blue solution in borax buffer for about 1 min. Excess stain was washed off with distilled water, and colonies were counted. Cells of the duplicate 6-well plate were submitted to a CPU-alkaline phosphatase (CFU-ALP) assay. Cultures were performed in normal medium for 7 days in order to obtain colonies and to remove contaminating cells, after which osteogenic medium was added for 2 weeks. Follow­ing this period, cells in the CFU-ALP plate were rinsed with PBS, fixed in 4% formaldehyde, and incubated for 10 min in a 0.2 M TRIS-hydrochloride (pH 10), 0.2 M calcium chloride, 0.1 M magnesium chloride solution, whereafter a solution containing 0.2 M TRIS-hydrochloride (pH 10), 0.2 M calcium chloride, 0.1 M magnesium chloride, and 600 µl nitroblue tetrazolium/5-bromo-4-chloro-3-indolyl-phosphate was added for 30 min. The percentage of the colonies staining positive for ALP was determined. 
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Culturing of SVF cells 
ASCs from the abdomen and hip/thigh region were cultured up to passage 2 for an adequate and quantitative compar­ison of stem-cell proliferation and differentiation capacity. Single-cell suspensions of cryopreserved SVF cells were seeded at 5.0x106 nucleated cells/cm2 in normal culture medium. The cultures were maintained in a 5% CO2 incubator at 37°C in a humidified atmosphere. The medium was changed twice a week. When reaching 80%-90% confluency, cells were detached with 0.5 mM EDTA/0.05% trypsin (Invitrogen) for 5 min at 37°C and replated. Cell viability was assessed by using the trypan blue exclusion assay. A homogeneous population of ASCs was thus obtained from abdomen and hip/thigh region and was subsequently checked by determining growth kinetics and by analyzing the surface-marker expression profile of the ASCs. 
Growth kinetics of ASCs 
To determine the growth kinetics of cultured ASCs, ten T25 flasks per donor were seeded with 1x105 cultured AS Cs (passage 2 or 3). At several time points (between days 2 and 12) after seeding, cells from two duplicate flasks were harvested and counted. ASC numbers were plotted against the number of days cultured, and the exponential growing phase of the cells was determined. The population doubling time was calculated by using the formula: 
. . . Days in exponential phase 
Populatzon Doublzng Time = (log N2 _ log NI)/ log 2
where Nl was the number of cells at the beginning of the exponential growing phase, and N2 was the number of cells at the end of the exponential growing phase. 
Flow cytometry 
Single-cell suspensions of cultured ASCs from abdomen and hip/thigh region were phenotypically characterized by using fluorescence-activated cell sorting (FACS; FACSCalibur, Becton Dickinson, USA) as previously described (Varma et al. 2007). All monoclonal antibodies (mAbs) were of the immunoglobulin G 1 (IgG 1) isotype. Cells were stained with fluorescently labeled antibodies ( conjugated to fluorescein isothiocyanate, phycoerythrin, or allophycocyanin) against CD31, CD34, CD45, CD54, CD90, CD106, HLA-DR, and HLA-ABC (BO Biosciences, San Jose, Calif.), CD166 (ROI Research Diagnostics, Flanders, N.J.), CD105 (Caltag Laboratories, Burlingame, Calif.), CDl 17 (PharMingen, San Diego, Calif.), and CD146 (Chemicon, Temecula, Calif.). Nonspecific fluorescence was determined by incu-
bating the cells with conjugated mAb anti-human lgG 1 (DakoCytomation, Glostrup, Denmark). 
Chondrogenic and osteogenic differentiation 
The chondrogenic and osteogenic differentiation capacities of the cultured ASCs from the abdomen (n=4) and hip/ thigh region (n= 4) were studied. Chondrogenic differenti­ation was induced in cultured ASCs as previously described, with some modifications (Oedayrajsingh-Varma et al. 2006). In short, a 50-µl drop of a concentrated ASC cell suspension (8x106cells/ml, passage 2) was applied to a glass slide and allowed to attach at 3 7°C for 1 h. Then, 750 µl chondrogenic medium, consisting of DMEM, plus ITS+ Premix (final concentration in medium when diluted 1: 100 was 6.25 µg/ml insulin, 6.25 µg/ml transferrin, 6.25 ng/ml selenous acid, 1.25 mg/ml bovine serum albumin (BSA), 5.35 µg/ml linoleic acid; BD, USA), 10 ng/nl transforming growth factor- 131 (TGF-131; Bio­vision, ITK-diagnostics), 1 % FCS, 25 µM ascorbate-2-phosphate (Sigma, St. Louis, Mo.), 100 U/rnl penicillin,100 µg/ml streptomycin, and 2 mM L-glutamine, wasoverlaid gently. Cells were maintained in a 5% CO2/I%oxygen custom-designed hypoxia workstation (T.C.P.S.Rotselaar, Belgium) at 37°C in a humidified atmosphere,as this was shown to enhance chondrogenic differentiation(data not shown). Chondrogenic media were changed every2-3 days.For osteogenic differentiation, ASCs (passage 2) wereseeded at 5000 cells/cm2 and cultured in monolayer in osteogenic medium, consisting of normal culture medium supplemented with 10 mM 13-glycerol phosphate, 50 µg/rnl ascorbate-2-phosphate, and 100 ng/ml bone morphogenetic protein 2 (BMP-2, Peprotech EC, London, UK). Osteogenic medium was changed twice a week. 
(lmmuno )histochemistry 
(lmmuno )histochemistry was performed as described pre­viously (Oedayrajsingh-Varma et al. 2006). Cell nodules that formed under chondrogenic culture conditions were stained with Alcian blue (Sigma-Aldrich, Zwijndrecht, The Netherlands) at acidic pH for detection of proteoglycans. For the detection of collagen Type II, staining was performed with mouse monoclonal antibody II-116B3 (1 :50; Developmental Studies Hybridoma Bank, Iowa, USA) against human collagen Type II in PBS containing 1% BSA. Osteogenesis was visualized after 21 days of culture in osteogenic medium by Von Kossa staining to establish the formation of a calcified matrix, typical for mature osteo­blasts. The protocol used was as described previously (Varma et al. 2007) with only one modification of counter-
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staining the cytoplasm of the cells using fast green. Calcified extracellular matrix was visualized as black spots. 
Spectrophotometric ALP activity 
Early differentiation of MSCs into immature osteoblasts is characterized by ALP enzyme activity, with human MSCs expressing ALP as early as 4 days after induction, and maximum levels being observed at around 14 days after induction (Jaiswal et al. 1997). Therefore, cellular ALP activity was measured after culturing the ASCs in osteo­genic medium for 14 days. Cells were lysed with distilled water, and the ALP activity and protein content were determined. To determine ALP activity, p-nitrophenyl phosphate (Merck, Darmstadt, Germany) at pH 10.3 was used as the substrate, as described by Lowry (1955). ALP activity was expressed as micromole per microgram of protein in the cell layer. The amount of protein was determined by using a BCA Protein Assay reagent Kit (Pierce, Rockford, Ill., USA), and the absorbance was read at 540 nm with a microplate reader (Biorad Laboratories, Hercules, Calif., USA). 
Real-time polymerase chain reaction 
RNA isolation and reverse transcription were performed as previously described (Oedayrajsingh-Varma et al. 2006). Real-time polymerase chain reactions (PCR) were per­formed by using the SYBRGreen reaction kit according to the manufacturer's instructions (Roche Diagnostics) in a LightCycler 480 (Roche Diagnostics). cDNA (approximate­ly 5 ng) was used in a volume of 20 µl PCR mix (LightCycler DNA Master Fast Startplus Kit, Roche Diag­nostics) containing a final concentration of 0.5 pmol primers. Relative housekeeping gene expression for 18 S-
rRNA (18 S) and relative target gene expression for aggrecan (AGG), collagen Type II (COL2B), and collagen Type X (COLI Oal) regarding chondrogenic differentiation, and for collagen Type I (COLI a), osteopontin (OPN), and runt-related transcription factor 2 (RUNX-2) regarding osteogenic differentiation were determined. Primers (Invitrogen) used for real-time PCR are listed in Table 2. They were designed by using Clone Manager Suite software program version 6 (Scientific & Educational Software, Cary, N.C., USA). The amplified PCR fragment extended over at least one exon border, based on homology in conserved domains between human, mouse, rat, dog, and cow, except for the 18 S gene (encoded by one exon only). Amplified Col2B PCR products were electrophoresed on a 2% agarose gel and stained with ethidium bromide. For real­time PCR, the values of relative target gene expression were normalized to relative 18 S housekeeping gene expression. 
Real-time PCR data analysis 
With the Light Cycler software (version 4), the crossing points were assessed and plotted versus the serial dilution of known concentrations of the standards derived from each gene by the Fit Points method. PCR efficiency was calculated by Light Cycler software, and the data were used only if the calculated PCR efficiency was between 1.85-2.0. 
Statistics 
Kolmogorov-Smirnov tests were used to determine the normalcy of measurements and, if appropriate, their logarithmics. For the evaluation of yield and growth kinetics, means between two groups in one variable were compared by using the independent sample two-tailed t-
Table 2 PCR primer sets used for reverse transcription/PCR (18 S 18 S subunit, AGG aggrecan, COLlol collagen Type I, COL2B collagen Type II, COLJ0al collagen Type X, OPN osteopontin, RUNX-2 runt-related transcription factor 2) 
Gene Primer sets Accession number, product length (bp) 
18 S Forward: 5' GTAACCCGTTGAACCCCATT- 3' Human, NM_l0098, 151 bp Reverse: 5' CCATCCAATCGGTAGTAGCG 3' 
AGG Forward: 5'CAACTACCCGGCCATCC 3' Human, NM_001135, 160 bp Reverse: 5'GATGGCTCTGTAATGGAACAC 3' COLlru Forward: 5' AAGCCGAATTCCTGGTCT 3' Human, NM_000088, 195 bp Reverse: 5' TCCAACGAGATCGAGATCC 3' 
COL2B Forward: 5' AGGGCCAGGATGTCCGGCA 3' Human, NM_033150, 195 bp Reverse: 5' GGGTCCCAGGTTCTCCATCT 3' 
COLJ0al Forward: 5' CACTACCCAACACCAAGACA 3' Human, NM_000493, 225 bp Reverse: 5' CTGGTTTCCCTACAGCTGAT 3' 
OPN Forward: 5' TTCCAAGTAAGTCCAACGAAAG 3' Human, AF_052124, 181 bp Reverse: 5' GTGACCAGTTCATGAGATTCAT 3' 
RUNX-2 Forward: 5' ATGCTTCATTCGCCTCAC 3' Human, NM_001024630, 156 bp Reverse: 5' ACTGCTTGCAGCCTTAAAT 3' 
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test. Partial correlation was expressed as the Pearson correlation coefficient, r. For evaluation of gene expression, a repeated measures analysis of variance was used to determine significant differences when increasing time­points in one donor within one variable were compared. If levels of gene expression were below the detection limit (0.05), values were set at 10-2 (or log level at -2). All statistical tests used a significance level of cx=0.05. 
Results 
Effects of tissue-harvesting site on frequency of ASCs 
In a previous study, we demonstrated that the yield of nucleated cells in the SVF of adipose tissue from different tissue-harvesting sites was similar (Oedayrajsingh-Varma et al. 2006). To investigate whether the tissue-harvesting site affected the frequency of ASCs in the SVF in the present study, limiting dilution and CFU-F assays were performed. The outcomes of both types of assays were similar (Fig. la, b ). When combined, the SVF of adipose tissue harvested from the abdomen contained 5.1 ± 1.1 % ASCs (mean± SEM), whereas the percentage of ASCs in the SVF of adipose tissue harvested from the hip/thigh region was much lower (1.2±0.7%; Fig. le). This difference in ASC frequency between adipose tissue from the abdomen and hip/thigh region was significant (P=0.0009). 
Effect of tissue-harvesting site on frequency of CFUs having osteogenic differentiation potential 
Parallel to the CFU-F assay (Fig. lb), CFU-ALP assays were also performed to determine the percentage of the 
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CFUs capable of osteogenic differentiation. For adipose tissue from the abdomen, 54.9±12.1% (mean±SEM) of the CFUs stained positive for ALP, whereas the CFUs from adipose tissue of the hip/thigh region displayed an ALP positivity of72.8±8.1 % (Fig. 2). Apparently, no differences in osteogenic potential existed between ASCs from the two tissue-harvesting sites (P=0.43). 
Phenotypic characterization and growth kinetics of cultured ASCs 
Cultured ASCs (passages 2 to 4) from abdomen and hip/ thigh regions were phenotypically characterized. ASCs from both tissue-harvesting sites were demonstrated to be homogeneous populations staining positive for stem-cell­associated markers CD34, CD54, CD90, CD105, CD166, and HLA-ABC, and negative for hematopoietic/leukocytic/ endothelial markers such as CD31, CD45, CD106, CD146, and HLA-DR (Table 3). To determine growth kinetics, the population doubling time of ASCs from passages 2 to 3 was determined. When ASCs numbers were monitored over time, a cell growing curve was obtained showing an exponential growing phase, after which the cells reached confluency (Fig. 3a,b ). The mean population doubling time of the ASCs in the exponential growing phase was about 2 days when the adipose tissue was harvested from the abdomen and hip/thigh regions (abdomen: 2.1±0.8; hip/thigh: 2.3±0.3; mean±SEM; Fig. 3c). 
Effect of tissue-harvesting site on osteogenic differentiation potential of ASCs 
Differentiation of cultured ASCs into the osteogenic lineage was induced by culturing the cells in monolayer in 
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(n = 9) (n = G) (n = 7) (n = G) (n = 12) (n = 10) Fig. 1 Effect of adipose-tissue-harvesting site on the frequency of colony-forming unit (CFU) assay (CFU-F), with similar results. When adipose-derived stem cells (ASCs) in the stromal vascular fraction combined (c), a significant difference was detected in ASC frequency 
(SVF). After isolation of the SVF from adipose tissue of both tissue- between adipose tissue harvested from the abdomen and adipose tissue harvesting sites, the frequency of ASCs in the SVF isolates was harvested from the hip/thigh region (P-values: a limiting dilution: P= determined by using: (a) a limiting dilution assay (W) and (b) a 0.003, b colony-forming unit: P=0.05, c combined: P=0.0009) 
4
59
153655 Oedayrajsingh Varma BNW.indd   59 17-09-2021   13:39
� CFU-ALPICFU-F '-� P= 0.43 
,5: 100 0 
LL g 
:::, 0 u. 75 � � a.: 0 
50 0 :::, g 
 harvesting site on the osteogenic diffentiation capacity of CFU from the abdomen or hip/thigh regions. No significant difference is apparent in the CPU-alkaline phosphatase 
(CFU-ALP) frequency from the abdomen and hip/thigh region when corrected for CFU-fibro-blast 
(CFU-F). � � 25 0 
C: 0 
0 e LL abdomen hip/thigh 
(n = 7) (n =5) 




Table 3 Surface-marker expression of human cultured ASC at passages 3--4. Results are expressed as mean fluorescence (MF), with isotype control <4.25 (- MF<8.5; + 8.5<MF<100; ++ lO0<MF<lO00; +++ MF> 1000).
Cell-surface marker Cultured ASC (n=4) 
CD29 ++ CD31 CD34 + CD45 CD54 ++ CD90 +++ CD105 ++ CD106 CD146 CD166 + HLA-ABC ++ HLA-DR 
Effect of tissue-harvesting site on chondrogenic differentiation potential of ASCs 
The chondrogenic differentiation potential of ASCs was analyzed after culturing the cells in a micromass in chondrogenic mediwn containing TGF-j3. Within 24 h of culture, most of the cells formed nodules (n=7). PCR-amplified COL2B mRNA expression was detectable but not quantifiable after 7 days in ASCs from both the abdomen and hip/thigh region in most but not all donors (n= 5). As shown in Fig. 5a, cells from both tissue-harvesting sites displayed COL2B mRNA. Under non-chondrogenic conditions, no COL2B could be detected. AGG and COLI 0<Xl mRNA expression in all donors tested increased over time, AGG being up-regulated 2.4-fold (P=0.041) at day 7 when compared with day 4, and COLI 0<Xl being up­regulated four-fold (P=0.024) after 7 days (Fig. 5b,c). No significant differences were detected in chondrogenic gene expression between ASCs derived from the abdomen and 
HIPffHIGH 









Fig. 3 Effect of the adipose-tissue-harvesting site on growth kinetics of ASCs in vitro. a Growth kinetics of ASCs of a representative donor when adipose tissue was harvested from the abdomen. b Growth kinetics of ASCs when adipose tissue was harvested from the hip/ 
6 10 0 
days abdomen hip/thigh 
(n=t;) (n=7) thigh region. c Population doubling time was calculated from the exponential growing phase of the cells. There was no significant difference in population doubling time of ASCs from the abdomen and hip/thigh region (P=0.78, independent Student t-test). 
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Fig. 4 Effect of adipose-tissue­harvesting site on the osteogenic differentiation of cultured ASCs in vitro. a--c RUNX-2 (runt­related transcription factor 2; P= 0.002), COLfol (collagen type Ia; P= 0.024), and OPN (osteo­pontin; P=0.38) gene expression was measured after 0, 4, and 
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7 days (d) of osteogenic induc­tion, by using quantitative real­time polymerase chain reaction (qRT-PCR). No significant dif­ferences were detected in osteo­genic gene expression between ASCs derived from the abdo­men and ASCs derived from the hip/thigh region, at all three time points tested. d ALP activity was significantly increased after 14 days in the osteogenically stimulated cells (stim) compared with that in unstimulated cells 
(con; P=0.047). No statistically significant difference was ap­parent in ALP activity between ASCs derived from abdominal fat and ASCs from hip/thigh fat. e-g Von Kassa staining of ASCs from abdomen ( e) and hip/thigh region (t) after 21 days of culture in osteogenic medium and in control medium (g), showing mineralized matrix vis­ible as black spots. 
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ASCs derived from the hip/thigh region, at all three time points tested. Alcian blue staining demonstrated proteoglycan deposi­tion in the ASC nodules from both the hip/thigh region and abdomen (Fig. 5d). At higher magnification (Fig. 5e), the ASC nodules resembled cartilage-like tissue, composed of round cells, surrounded by lacunae and lying in a proteoglycan-rich extracellular matrix that appeared posi­tive for collagen Type II by immunostaining (Fig. 5t). 
Discussion 
In this study, we have investigated whether the yield and functional characteristics of ASCs are affected by the adipose tissue-harvesting site, i.e., abdomen and hip/thigh regions. We have found a difference in the frequency of ASCs between adipose tissue harvested from the abdomen 
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and the hip/thigh regions. SVF isolates derived from abdominal fat contain significantly higher frequencies of ASCs. When cultured, the growth kinetics and surface­marker expression of ASCs from both tissue-harvesting sites are similar. We have detected no differences in osteogenic or chondrogenic differentiation potential between these cultured ASCs from the two tissue-harvesting sites. Adipose tissue is a highly heterogeneous tissue, not only among individuals, but also when comparing different fat depots within one individual. Donor-dependent differences have been demonstrated to exist in (stem) cell yield, proliferation, and differentiation capacity, probably caused by differences in age (Rauner and Entenmann 1991; van Harmelen et al. 2003), BMI (Aust et al. 2004; Hauner et al. 1988; Jaiswal et al. 1997; van de Venter et al. 1994), and diseases such as osteoarthritis and diabetes (Barry 2003; Murphy et al. 2002; Ramsay et al. 1995). Donors used in this study for harvesting adipose tissue were healthy female 
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Fig. 5 Effect of the tissue-harvesting site on the chondrogenic differentiation of cultured ASCs in vitro. a Both abdomen (lane 1) and hip/thigh region (lane 2) display COL2B mRNA. Under nonchondrogenic conditions, no COL2B could be detected (lane 3). b, c Aggrecan (AGG; P=0.041) and collagen lOA (CollOa; P=0.024) gene expression, respectively, was up-regulated after 7 days (d), as measured by qRT-PCR. No significant differences were detected in chondrogenic gene expression between ASCs derived from the 
donors up to 62 years old. Some patients who will benefit from tissue engineering of cartilage will be older or might suffer from disease, and males will also be affected. Therefore, future research should include these donor types to determine whether yields and functional characteristics are influenced by these variables. In our donor population, no significant correlation has been detected between the frequency of ASCs and the age of the donor (P=0.32, r=0.27) or between the frequency of ASCs and BMI (P=0.42, r=-0.22; data not shown). These data are in agreement with other studies that have demonstrated no correlation between BMI or age and numbers of ASCs per gram of adipose tissue (Rauner and Entenmann 1991; van Harmelen et al. 2003). Most importantly, this means that these variables cannot be responsible for the difference that we have found between the frequency of ASCs and the tissue-harvesting site. In addition to donor-dependent heterogeneity, intra­individual differences between fat depots have been demonstrated, e.g., with regard to the metabolic response 
abdomen and ASCs derived from the hip/thigh region, at all three time points tested. d, f Cartilaginous matrix expression was visualized in both tissue-harvesting sites by staining proteoglycans (Alcian blue) and COL2 (Col2-116B3 antibody), respectively. e At higher magnifi­cation, the ASC nodles resembled cartilage-like tissue, composed of spherical cells sunuunded by lacunae and lying in a proteoglycan-rich extracellular matrix. 
of adipose tissue to various hormonal and neurological stimuli (Guilak et al. 2004; Lacasa et al. 1997; Masuzaki et al. 1995; Monjo et al. 2003; Rodriguez-Cuenca et al. 2005) and the cellular composition of the adipose tissue (Peptan et al. 2006; Prunet-Marcassus et al. 2005). In this study, we have focused on the intra-individual differences in the yield and function of ASCs from two fat depots: the abdomen and the hip/thigh region. We have demonstrated that adipose tissue derived from the abdomen contains signifi­cant higher frequencies of stem cells compared with adipose from the hip/thigh region. Whereas SVF isolates from the abdomen in this study contain about 5.1 % of ASCs, the frequency of ASCs in SVF from the hip/thigh region is only 1.2%. Moreover, this 1.2% is the average of a population in which some donors hardly possess any adipose-derived stem cells (see spreading ASC frequency hip/thigh in Fig. 1). Despite this more than four-fold difference, the frequency of ASCs in adipose tissue from the hip/thigh region is still much higher compared with the frequency of MSCs in the bone marrow compartment, 
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which is as low as 0.001%---0.01% (Pittenger et al. 2000), thereby making the hip/thigh region still a much more attractive stem-cell source for tissue engineering therapies. What are the implications of these stem-cell frequencies for clinical practice? We have shown that 0.5-2.0x 108 SVF cells can be harvested from 100 g adipose tissue, an amount that can easily be obtained from a patient (Aust et al. 2004; De Ugarte et al. 2003; Oedayrajsingh-Varma et al. 2006; Zuk et al. 2001). With an ASC frequency of 5.1 %, the SVF isolates contain between 2.6-10.2x 106 stem cells, which is an amount that appears to be sufficient for cell-based therapies as compared with the amount of cells used by others (Erickson et al. 2002; Fan et al. 2006; Williams et al. 2003; Zheng et al. 2006). This implies that time-consuming culturing and expanding steps of the stem cells can be avoided. In comparison, a bone marrow transplant of 100 ml contains approximately 6.0x 108 nucleated cells (Zuk et al. 2002), of which only 0.001 %---0.01 % (0.06-0.006x 106 cells) are stem cells (Pittenger et al. 2000). To determine the frequency of CFU capable of differenti­ating into the osteogenic lineage, a CFU-ALP assay has been performed on cells from the abdomen and hip/thigh region. The frequencies ofCFU-ALP (±3%) are almost comparable with those of the CFU-F (Figs. lb, 2). This is higher than the value that Mitchell et al. (2006) have found in their clonogenic assay of freshly isolated stromal cells (±0.5%). However, they have used a different assay method and shorter incubation period, and their frequency increases to the same level (5%) after progressive passaging (Mitchell et al. 2006). SVF cells have been cultured up to passage 3 to obtain a homogeneous population of ASCs as starting material for differentiation studies toward the chondrogenic lineage. When comparing the growth kinetics of these cultured ASCs from the abdomen and hip/thigh region, the cell doubling time appears to be similar, being approximately 2 days. This is in accordance with the findings of others who have compared the replication rate of adipocyte precursor cells from various tissue-harvesting sites (Hauner et al. 1988; Pettersson et al. 1985; Roncari et al. 1981; Zuk et al. 2001). On the other hand, when comparing SVF cells from omental and subcutaneous fat, van Harmelen et al. (2004) have found a difference in cell proliferation rate; however, this may be explained by differences in methodological approach, since they use stromal cells instead of cultured ASCs. As we have shown that different fat depots contain different numbers of stem cells, these differences in proliferation rate may be caused by differences in initial stem-cell numbers when using SVF cells. This is reflected in the fmding that, in our study, SVF cells derived from abdominal fat reach 80%-90% confluency within 5 days, whereas SVF cells derived from adipose tissue of the hip/thigh region take more than 
9 days to reach 80%---90% confluency when seeded in the same density (data not shown). In addition to the determination of growth kinetics, we have phenotypically characterized the cultured ASCs. The surface-marker expression profile is in accordance with those found by others (Mitchell et al. 2006; Schafller and Buchler 2007; Varma et al. 2007), making both tissue sites fully comparable with each other (Tables 1, 3). The homogeneous ASC population has been induced to the osteogenic and chondrogenic lineages. Having deter­mined the osteogenic differentiation capacity of ASCs, we have shown significant up-regulation of osteogenic gene expression, ALP activity, and matrix mineralization. Inter­estingly, although no significant difference has been detected in ALP activity between ASCs from the abdomen and hip/thigh regions, ASCs from the hip/thigh region tend to show higher values of ALP activity after induction. This might be related to the underlying bone tissue, thereby implying that the ASCs of the hip/thigh region are less multipotent and more committed to the osteogenic lineage. The chondrogenic differentiation capacity of the ASCs has been demonstrated by the up-regulation of AGG and COLl0cxl gene expression and the production of matrix proteins. No difference has been detected in the chondro­genic differentiation potential between ASCs from the abdomen and hip/thigh regions. However, in the PCR studies, we have not succeeded in quantifying COL2cx and Col2B mRNA expression for any of the donors tested. Others have obviously faced the same difficulty when trying to measure the up-regulation of COL2B genes in MSCs (Huang et al. 2004; Winter et al. 2003; Zuk et al. 2002). Although intending to measure collagen Type X mRNA expression as a hypertrophic and therefore late marker of chondrogenesis, we have noticed that this mRNA is expressed earlier than collagen Type II mRNA. This is surprising, as we would expect stem cells to have to differentiate into chondrocytes before they can become hypertrophic. However, this unexpected hierarchy of chon­drogenic gene expression has also been found by Mwale et al. (2006). Moreover, both Mwale et al. (2006) and we have found AGG to be constitutively expressed in MSCs. Because of this constitutive expression of AGG and the early up­regulation of COLl0cxl, Mwale et al. (2006) warn against using these molecules as markers for chondrogenesis and chondrocytic hypertrophy. We think that these genes can nevertheless be used as markers for differentiation into the chondrogenic lineage, albeit being exclusively shown as the quantitative up-regulation of gene expression, and always in combination with other chondrogenic markers ( an awareness of the possible difference in the function of COLlOcxl in chondrogenesis in adult stem cells when compared with embryonic stem cells is also necessary). 
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Our lack of detection of any significant differences in the osteogenic and chondrogenic differentiation potential when comparing ASCs from the two tissue-harvesting sites seems to be in contrast with studies of Rauner and Entenmann 1991) who have found differences in the adipogenic differentiation potential between SVF cells from abdominal and femoral adipose tissue. However, since Rauner and Entenmann 1991) have used fresh SVF cells instead of culture-passaged ASCs, the variation in differentiation potential might be attributable to differences in numbers of ASCs in the SVF isolates of the two regions, as we have shown in this study. Other factors responsible for the variation in differentiation potential can be ascribed to other specific histological characteristics of the adipose tissue at the anatomical site, such as vascularity and amount of fibrous tissue (Lennon et al. 2000; Peptan et al. 2006; Pittenger et al. 2000), and to differences in the regulation of gene expression (Djian et al. 1983; Peptan et al. 2006; Pittenger et al. 2000). We therefore conclude that the yield of ASCs is de­pendent on the tissue-harvesting site. In planning the optimal one-stage procedure for the regeneration of cartilage tissue, factors that can positively influence the outcome of the operation must be taken into account. In view of this, the abdomen seems to be preferable to the hip/thigh region for harvesting ASCs. 
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A comparison in therapeutic efficacy of several time points of 
intravenous StemBell administration in a rat model of acute 
myocardial infarction 
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Abstract Background. Adipose-derived stromal cells (ASCs) are a promising new therapeutic option for patients with acute myo­cardial infarction (AMI). Previously, we found that ASCs coupled to antibody-targeted microbubbles (StemBells [StBs]) improved cardiac function when administered intravenously 7 days post-AMI in rats. In this study, we compared the effi­cacy of intravenous StB administration at different administration time points following AMI in rats. Merhods. AMI, followed by reperfusion, was induced in four groups of male Wistar rats, which subsequently received an intravenous 1 x 106 StB 
bolus 1 day post-AMI (StBl; n = 8), 7 days post-AMI (StB7; n = 9), at both time points (StB1+7; n = 7) or neither (Control; n = 7). The effect onrdiac function was determined using echocardiography prior to AMI, 7 days post-AMI and 42 days post-AMI. The effect on infarct size and macrophages in the infarct core were determined (immuno)histochemically 42 days post-AMI. Results. At 42 days post-AMI, all three StB groups had a significantly improved fractional shortening com­pared with the control group. Between the StB-treated groups, the effects did not differ significantly at 42 days post-AMI. At 7 days post-AMI, the StBl group had a significantly improved fractional shortening compared with the control and StB7 groups. No significant changes in infarct size or macrophage numbers were found compared with the control group for any StB group. Conclusions. StB administration resulted in long-term improvement of cardiac function, independent of the time point of administration. When administered at 1 day post-AMI, this improvement was already evident at 7 days post-AMI. 
Key Words: adipose tissue, intravenous administration, microbubbles, myocardial infarction, stromal cells 
Introduction 
Acute myocardial infarction (AMI) is a major cause of death and morbidity worldwide [1]. A potential treat­ment option for AMI is mesenchymal stromal cell administration [2]. Adipose tissue forms an attrac-
tive source to obtain mesenchymal stromal cells (adipose-derived mesenchymal stromal cells [ASCs]), as it is easily accessible and stromal cell-rich [3]. ASCs have been demonstrated to differentiate into several intra-cardiac cell types [4,5], and secrete paracrine factors that can stimulate cardiac regeneration [6,7]. 
"These authors contributed equally to this work. Correspondence: Reindert W. Emmens, PhD, Departiment of Pathology - 0E46, VU University Medical Center, 1081 HV Amsterdam, The Netherlands. E-mail: r.emmens@vumc.nl 
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mouse-anti-rat-ICAM-1 (1 µg; Acris antibodies) were added, and the mixture was incubated at 4°C for 25 min. These dual-targeted microbubbles were again washed, and resolved in DMEM. To assemble the StBs, ASCs were incubated with dual-targeted micro bubbles in a 1: 100 ratio under continuous ro­tation at room temperature for 25 min. A minimum of 10 micro bubbles were coupled to each ASC. 
Induction of AMI in rats 
MaleWistar rats (Harlan) were anesthetized using sub­cutaneous hypnorm/dormicum (fentanyl and fluanison 0.5 mIJkg, midazolam 5 mg/kg) injection, and were ventilated at 75 breaths/min, 10-0.4 mbar (Zoovent ventilator, Instruvet). Heart rate was monitored using Einthoven I electrocardiography (ECG). A left tho­racotomy in the fourth intercostal space was made, and the left anterior descending coronary artery (LAD) was ligated using a 6.0 prolene suture (Ethicon). Isch­emia was maintained for 40 min, followed by reperfusion and chest closure. This procedure results in relatively small non-aneurysmatic infarcts, compa­rable with what occurs in the majority of patients suffering from AMI. A total of 48 rats was subjected to the procedure, of which 31 were used for analy­sis. The other 17 rats either died during surgery or were excluded due to an unsuccessful LAD ligation. 
Experimental procedures 
After induction of AMI, the rats were subdivided into four groups: Control (n = 7), StBl (n = 8), StB7 (n = 9) and StB1+7 (n = 7). For ethical reasons concerning animal use, we compared the StB 1 and StB 1 + 7 groups with the same control and StB7 groups used previ­ously [11]. One day post-AMI, the rats in the StBl and StB 1 + 7 groups received a bolus of 1 x 106 StBs in 600 µL DMEM in the tail vein. Seven days post­AMI, the rats in the StB7 and StB1+7 groups received a bolus of 1 x 106 StBs in 600 µL DMEM in the tail vein as well. At both time points, the injections were performed under 3 % isoflurane anaesthesia, and rats received ultrasound exposure following injection. Ul­trasound was applied using a 1-MHz unfocused transducer (V303-SU, Panametrics Inc) or a 500kHz PZT transducer (V318, Panametrics Inc), coupled to an arbitrary waveform generator (33220A,Agilent) and a linear 60-dB power amplifier (150Al 00B, Ampli­fier Research). The transducer was placed parastemal at the anterior wall, and location of the infarcted area and rats were exposed to sine-wave ultrasound bursts with a 10% duty cycle and 1 kHz pulse repetition fre­quency for 1 min. The ultrasound signal was monitored by a synchronized digital oscilloscope (GOUl.D DSO 465). Peak negative acoustic pressure was 100 kilopascal (kPa), as verified with a calibrated hy-
 
drophone (PA076; Precision Acoustics). Rats were humanely killed 42 days post-AMI, after which the hearts were isolated, fixed in 4% formaldehyde, sliced transversally and embedded in paraffin. For infarct size determination and macrophage quantification, two sections were examined per heart, one section ap­proximately 2 mm above the tip of the apex and the other approximately 2 mm below the site where the LAD was ligated. 
Analysis of cardiac function 
For analysis of cardiac function, transthoracic short­axis 2-dimensional (2D)-echocardiography was performed immediately prior to AMI, immediately prior to the second administration time point (7 days post-AMI), and immediately prior to humane killing (42 days post-AMI), using a 13 MHz linear-array trans­ducer (ProSound SSD-4000 PureHD, Aloka). Echocardiographic images were analyzed using Image­Arena 2.9.1 (TomTec Imaging Systems). To ensure that the (repeated) measurements in the rats were taken at the same mid-ventricular location, the echocardiographic images were recorded using the at­tachment site of the papillary muscle for orientation. For each rat and time point, lumen diameter and wall thickness were measured in three separate images, and the average values of the three images were used for the analysis. The fractional shortening (FS) was de­termined by calculating the degree of shortening of left ventricular diameter between end-systole and end­diastole. Contraction of posterior and anterior walls was determined by calculating the difference between end-systolic and end-diastolic wall thickness. 
Infarct size determination 
To determine the infarct size of the StBl and StB1+7 groups, an Elastica von Giesson (EvG) staining was performed on 4-µm thick paraffin-embedded heart slides. Slides were placed in ethanol and washed in regular tap water. Next, the slides were placed in Law­son's solution (Klinipath) for 30 min, followed by a brief (several seconds) immersion in 100% ethanol. The slides were washed, stained with hematoxylin, washed again and placed in Van Giesson solution (satu­rated picric acid solution with 0.075% fuchsine acid) for 5 min. Surplus fluid was drained after which the slides were air dried and covered. The slides were scanned using a Pannoramic DESK digital slide scanner (3DHistech Ltd.), and surface areas of the magenta-stained infarct areas, as well as the total cross­sectional surface areas of the hearts, were measured using Pannoramic Viewer vl .15.3 (3DHistech Ltd.). The infarct size was determined as the mean relative infarct size of both sections, and compared with infarct 
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Figure 2. Wall contraction and thickness. (A) Time-lapsed echocardiographic image (left ventricular short-axis view) of a control rat created 
at day O and day 42, displaying the wall thickness (yellow line) during systole (S) and diastole (D). (B and C) Mean contraction (systolic 
wall thickness relative to diastolic wall thickness) of the anterior wall, compared between different time points within each experimental 
group (B) and compared between different experimental groups within each time point (C). (D) Mean contraction (systolic wall thick­
ness relative to diastolic wall thickness) of the posterior wall, compared between different time points within each experimental group. (E 
and F) Diastolic wall thickness of the anterior wall (E) and posterior wall (F) compared between different time points within each exper­
imental group. (G) Diastolic wall thickness of the posterior wall compared between different experimental groups within each time point. 
Error bar: standard error of the means. *P< 0.05 compared with the control group. **P < 0.01 compared with day 0. ***P< 0.001 com­
pared with day 0. #P < 0.05 compared with 7 days post-AMI. The symbol color above the data points in part B indicates the group for 
which a significant difference was found. Of one control rat (all time points) and one rat from the StBl group (day 0), echocardiographic 
images were of insufficient quality for wall analysis. 
compared with the control and StB7 groups, which was significant for the StB 1 group (Figure 1 C). At 42 days, the FS of the control group (0.28 ± 0.02) did not differ significantly compared with day 7 and remained significantly lower compared with baseline (Figure IB). Compared with the control group, at 42 days the StBl group (0.46 ± 0.04), the StB7 group (0.41 ± 0.04) and the StB1+7 group (0.44 ± 0.03) all showed a significantly improved FS, but did not differ significantly between each other (Figure 1 C). In summary, in the long term ( 42 days post­AMI) StB administration at 1 day post-AMI, 7 days post-AMI or at both time points all similarly coun-
teracted the AMI-induced effects on FS. In addition, StBs administered at 1 day post-AMI resulted in a higher FS in the short term (7 days post-AMI) com­pared with the control group. 
The effect of different StB administration time points on cardiac muscle contraction 
Next, we investigated the effects of StB administra­tion on the contraction of the anterior wall ( containing the infarction) and the (non-infarcted) posterior wall (Figure 2A), expressed as the end-systolic wall thick­ness relative to the end-diastolic wall thickness. At 
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The effect of different StB administration time points on macrophages 
Finally, we analyzed whether the long-term benefi­
cial effects of StB therapy were related to effects on 
cardiac inflammation. For this, we quantified the 
density of macrophages present in the heart 42 days 
post-AMI because macrophages are known to remain 
present in increased numbers for an extended period 
of time in the infarcted myocardium whereas other in­
flammatory cells do not [17]. Virtually no macrophages 
were observed outside of the infarct area in any of the 
groups (not shown). In the infarct area, the total 
number of macrophages in the control group 
(225 ± 46 cells/mm2) did not significantly differ com­
pared with the StBl group (220 ± 41 cells/mm2), the 
StB7 group (132 ± 27 cells/mm2) or the StB1+7 group 
(182 ± 31 cells/mm2; Figure 4A). Compared with StBl, 
however, the total number of macrophages was sig­
nificantly decreased in the StB7 group. Similar to the 
total number of macrophages, the number of CD 163-
positive macrophages (the anti-inflammatory M2 
macrophage subset) did not differ significantly between 
the control group (193 ± 35 cells/mm2), the StBl group 
(161 ± 2 cells/mm2), the StB7 group (115 ± 29 cells/ 
mm2) and the StB1+7 group (134 ± 23 cells/mm2; 
Figure 4B). Also, the percentage of CD163-positive 
macrophages relative to the total number of mac­
rophages was comparable between groups (87 ± 6%, 
82 ± 9%, 81 ± 6% and 75 ± 9% for control, StBl, StB7 
and StB1+7, respectively; Figure 4C). 
In summary, the long-term functional improve­
ment of the heart does not relate to the state of cardiac 
inflammation (macrophages) at day 42. 
Discussion 
The aim of this study was to compare in rats the ther­
apeutic efficacy of StB administration 1 day post­
AMI with administration 7 days post-AMI. At 42 days 
post-AMI, both time points of administration re­
sulted in a similar improvement of cardiac function. 
Additionally, StB administration prevented long­
term posterior wall hypertrophy independent of 
administration time-point. However, despite that these 
long-term effects were equal, StB administration 1 day 
post-AMI resulted in an improved cardiac function, 
measured at 7 days post-AMI. A second StB bolus ad­
ministered at 7 days post-AMI provided no additional 
long-term functional benefits. Interestingly, the ob­
served functional benefits did not correlate with a 
significant reduction in infarct size, nor a significant 
reduction of residual cardiac inflammation at 42 days 
post-AMI. 
Theoretically, the improved cardiac function ob­
served at day 7 post-AMI after StB administration 1 




















� � 80 
a.a. 
00 
t; t; 60 
c,s c,s 
EE 
+ - 40 ra� ... -
c ..,_ 20 CJ 0 
� 0 
* 
Control SIB 1 SIB 7 SIB 1+7 
Control SIB 1 SIB 7 SIB 1+7 
Control StB 1 StB 7 StB 1+7 
Figure 4. Macrophages. (A) Mean macrophage numbers per mm2 of infarcted tissue, compared between experimental groups at day 42. (B) Mean CD163-positive macrophage numbers in the infarctarea compared between experimental groups at day 42. (C) CD163-positive macrophage numbers, relative to total macrophage numbers, compared between experimental groups at day 42. Error bar: stan­dard error of the means. *P< 0.05. Of two control rats and one rat of the StB1+7 group, cardiac tissue was insufficient for mac­rophage analysis.
ated infarct expansion during the first week following 
AMI. However, we did not find significant differ­
ences in infarct size between the groups at 42 days 
post-AMI. Despite the absence of a significant infarct 
size reduction, the contraction of the (infarcted) an­
terior wall was significantly improved at day 42 for the 
StBl and StB1+7 groups compared with the control 
group. In line with this, cardiac hypertrophy in the non­
infarcted myocardium is a well-known compensatory 
response to the reduced contractile function of the in­
farcted myocardium [18]. The observed reduction in 
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data indicate that StB administration 1 day post­
AMI is preferable over 7 days. An additional practical 
advantage of StB administration 1 day post-AMI is 
that this allows the administration during the initial 
hospitalization period of the patients with AMI, which 
in modem times is generally less than 4 days follow­
ing the ischemic event [34]. 
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Abstract 
Background: Acute myocardial infarction (AMI) induces a 
pro­inflammatory status of the intramyocardial vasculature in which 
Nc­ (carboxymethyl)lysine (CML), an advanced glycation end 
product, and NOX2, a source of reactive oxygen species (ROS), 
play an important role. As such they form attractive therapeutic 
targets to prevent future heart failure development. Previously, 
we found that adipose tissue derived stem cells coupled to 
antibody-targeted microbubbles (the so-called StemBells (StB)) 
improved cardiac function when administered intravenously, 
also when applied early after AMI in a rat model. Its effect on 
the intramyocardial microvasculature however is unknown. In the 
present study we have analyzed its effect on both CML and NOX2 
depositions in the intramyocardial vasculature in a rat AMI model. 
Methods: AMI was induced by ligation of the left coronary artery 
followed by reperfusion in male Wistar rats. In a subset of these 
rats, intravenous StB were administered at day 1 (n=8) (group StB 
day 1 ), day 7 (n=7) (group StB 7) or days 1 and 7 (n=7) (group StB 
day 1 + 7) post-AMI. Animals were sacrificed at day 42 post-AMI. 
The effect on CML (immunohistochemical score and/or the 
number of blood vessels with different intensity scores) and 
NOX2 positivity (the number of positive blood vessels) was then 
analyzed using immunohistochemistry. 
Results: AMI induced a significant increase in both CML (from 0.08 
± 0.01 /mm2 in controls up to 0.3 ± 0.05/mm2 in the AMI group) 
and NOX2 positivity of the intramyocardial vasculature (from 0.1 
± 0.01 in non-infarcted control rats to 0.53 ± 0.08 in AMI rats). 
StB therapy significantly decreased NOX2 (0.11 ± 0.02 treated 
on day 1 post-AMI, 0.19 ± 0.02 when treated on day 7 post-AMI 
and 0.25 ± 0.04 with administration at day 1 and day 7 
post-AMI), without significant differences between the three 
StB groups) and CML positivity (immunohistochemical score: 
0.13 ± 0.03 when treated at day 1 post-AMI, 0.17 ± 0.02 when 
treated on day 7 post-AMI 
and 0.13 ± 0.01 with treatment on day 1 and day 7 post-AMI) of 
the intramyocardial vasculature in all three groups. A significant 
decreasing effect of StB therapy on the lowest CML intensity (score 
1) was found in all three StB groups, on the intermediate (score 2) 
in the StB day 7 and StB day 1+7 group, and finally on the highest 
CML intensity (score 3) in the StB day 1 + 7 group only.
Conclusion: StB therapy reduced the pro-inflammatory status of 
the intramyocardial vasculature post- AMI when applied in the acute 
phase post-AMI. 
Keywords 
NOX2, AGE, Stem cells, Myocardial infarction, Inflammation 
Introducbon 
Heart failure (HF) development after acute myocardial infarction (AMI) is a leading cause of morbidity and mortality in the western world [1,2]. Post-AMI inflammation is playing an important role in the development of HF. One of the best characterized advanced glycation end products (AGE), NE-(carboxymethyl)lysine (CML) [3] has been described in the intramyocardial vasculature before but also subsequent to AMI [ 4-6]. This suggest that AGEs not only play a role in the induction of AMI but also in the jeopardizing inflammatory response post-AMI and as such could even play a role in the process of re-infarction and/or HF development. CML accumulation has been associated with increased oxidative stress [7] and it has been shown that its accumulation coincides with the activation ofNOX2 proteins, a source of reactive oxygen species (ROS) in the heart [ 8,9]. Inhibiting CML and/or NOX2 in the intra myocardial vasculature might thus form a putative therapy to prevent cardiac complications post-MI. 
Adipose derived stem cells (ASC), have emerged as an important element of regenerative therapies [10] partly due to their capacity of paracrine secretion of a broad selection of anti-inflammatory cytokines, chemokines, and growth factors making them clinically attractive as an anti-inflammatory and immunomodulatory therapy [11-13]. To improve stem cell therapy, we have coupled ASCs to gas­filled microbubbles that were coated with antibodies to Intercellular Adhesion Molecule (ICAM- 1 ), to create the so-called StemBells (StB). ICAM-1 is increased on activated endothelial cells in the heart post-AMI and CD90 (an ASC surface marker). These injected StB, can be pushed against the vessel wall using ultra-sound to increase their adherence [14]. Intravenously injected StB significantly improved cardiac function on the long term (42 days post-AMI) in a rat model of AMI, even when applied at 1-7 days post-AMI when the post­AMI induced inflammatory response is especially high. However, intravenous injected StB did not show an effect on infarct size [15]. 
In this study we have analyzed whether StB could influence the pro-inflammatory status of the intramyocardial vasculature by analyzing its effect on both CML and NOX2 depositions in the intramyocardial vasculature in a rat AMI model. 
Materials and Methods 
The rat AMI model 
We used tissue specimen of a recent study in which the effect of the StB application was studied in a rat AMI model [16]. In short, 
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eight-week old male Wistar rats (300-400 g, Harlan, the Netherlands) [17] were anaesthetized using fentanyl/fluanison (0.5 ml/kg)and midazolam (5 mg/kg). Subsequently, AMI was induced vialigation of the left anterior descending coronary artery (LAD). After40 minutes the ligation was removed to allow reperfusion. All animalexperiments were performed according to national guidelines andwere approved by the Institutional Animal Care and local AnimalEthical Committee of the Vrije Universiteit (VU) University MedicalCentre (Amsterdam, the Netherlands).
Stem Bell treatment 
Sill were assembled using stem cells that were isolated from adipose tissue that was harvested from the inguinal fat pads of 18 male Wistar rats (Harlan, Horst, the Netherlands) [16]. Subsequently, biotinylated mouse-anti-rat-CD90 antibodies (1 µg; BD Biosciences, Franklin Lakes, NJ) and biotinylated mouse-anti-rat­ICAM-1 antibodies (1 µg; Acris antibodies, Herford, Germany) were coupled to biotinylated microbubbles using streptavidin (1 mg/ml; Sigma-Aldrich) as a linker. To create Sill, the antibody­loaded microbubbles were then coupled to the ASCs, as described previously [13,16]. 
The rats were separated in 5 different groups: a control group (rats without AMI and without Sill therapy, n=7), an AMI group (rats with AMI, without StB therapy, n=6), and three therapy groups (Sill groups): rats with AMI and with StB therapy given either on day 1 post-AMI ( n=8), on day 7 post-AMI (n=9) or both on days 1 and day 7 (1+7) post-AMI (n=7). The StB (1 x 106 in 600 µl DMEM) were administered in the tail vein. Rats without therapy received a control injection of 600 µl DMEM. The rats were sacrificed 42 days post-AMI, and the hearts were excised and fixed in 4% formaldehyde and then paraffin embedded for immunohistochemical analysis. 
Immunohistochemical staining for CML and NOX2 
For immunohistochemical analysis, paraffin embedded heart slides, 4-µm thick, were deparaffinized for 10 minutes in xylene followed by dehydration with ethanol and incubation in methanol 
I H202 (0.3%) for 30 minutes to block endogenous peroxidases. Antigen retrieval for CML staining was performed by incubating the slides in 0.1 % pepsin buffer for 30 minutes at 37°C, for NOX2 stainingby boiling the slides in a TRIS/EDTA buffer (pH 9.0) for 10 minutes. All sera and antibodies were diluted in Normal Antibody Diluent Solution (Immunologic). The slides were incubated for 1 hour with a mouse anti-human CML antibody (1:500 dilution) [18] or a mouse anti-human NOX2-antibody [19]. After washing in PBS, the slides were incubated with a biotin-conjugated rabbit-anti-mouse antibody (1:500 dilution, Dako) for 30 minutes, followed by subsequent washing with PBS. The slides were then either incubated with streptavidin-HRP complex (1:500 dilution, Dako) for CML staining, or with the ABC-kit (1:100 dilution, Vector Lab, Burlingame, CA) for NOX2 for 1 hour. After visualization with 3,3' diaminobenzidine (DAB, Dako), the slides were stained with hematoxylin, dehydrated and covered. 
Tissue analysis 
Two cross-sections were examined per heart, one section approximately 2 mm above the tip of the apex and the other approximately 2 mm below the site where the LAD was ligated. 
Quantification of the immunohistochemical staining of CML was performed as follows: for the intensity scoring each CML-positive blood vessel was given a score of l= weak positive; 2=moderately positive; or 3=strongly positive. Additionally, the surface area of the tissue was measured using QPRODIT [18]. To obtain the immunohistochemical (IH) score per mm2, first each intensity score (1, 2 and 3) was multiplied by the number of vessels positive for this score. These multiplication scores were added and divided by the tissue area resulting in an immunohistochemical score per mm2 [19]. NOX2-positive blood vessels were counted and related to the surface area of the analyzed tissue (measured using QPRODIT) [18]. 
Statistical Analysis 
Data analysis was performed with Prism v.4.0 (Graphpad Software, La Jolla, CA). One-way ANOV A combined with Tukey posthoc test was used to analyze the differences between groups. Data values in text are displayed as mean ± standard error. P<0.05 was considered statistically significant for all the performed analyses. 
Results 
CML depositions in the intramyocardial vasculature 
CML depositions in the intramyocardial vasculature (Figure 1) were quantified at day 42 post-AMI in the ventricles. AMI of the anterior wall induced a significant increase in CML IH score(from 0.08 ± 0,01 /mm2 in controls up to 0.3 ± 0.05/mm2 in the AMI group(p<0.05, Figure 2). In all three Sill groups, the CML IH-score was significantly lower than in untreated AMI rats ( 0.13 ± 0.03 (StB­treatment on day 1 post-AMI), 0.17 ± 0.02 (Sill-treatment on day 7 post-AMI) and 0.13 ± 0,01 (StB- treatment on days 1+7 post-AMI)). We found no significant differences between the different Sill treated groups, neither between the three StB treated groups and the control group. 
We subsequently analyzed the effects of Sill therapy on the number of blood vessels positive for a particular CML intensity score (Figure 2). AMI induced a significant increase in the numbers of weak, moderate and strong CML-positive blood vessels. The number of weak CML-positive vessels with a score 1 was significantly reduced to control levels in all three Sill therapy groups, without differences between the three Sill groups (Figure 2). The number of moderate CML-positive vessels was decreased significantly only by Silltreatment on day 7 and on days 1+7 post-AMI. Finally, the numberof strong CML-positive vessels was only significantly reduced by Silltreatment on days 1 + 7 post AMI.
NOX2 positive blood vessels 
AMI induced a significant increase in the number of NOX2-positive blood vessels from 0.1 ± 0.01 in non-infarcted control rats to 0.53 ± 0.08 in AMI rats (Figures 1 and 3). In all three Sill therapy groups the number of NOX2 positive blood vessels decreased significantly (to 0.11 ± 0.02 (Sill-treatment on day 1 post-AMI), 0.19 ± 0.02 (Sill-treatment on day 7 post-AMI) and 0.25 ± 0.04 (Sill-treatment on days 1+7 post-AMI)). No significant differences between the three Sill groups were measured. The number of NOX2 positive blood vessels in the three Sill groups was not significantly different compared with control rats. 
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Figure 1: lmmunohistochemical staining of heart tissue of AMI rats treated with SIB for (A) CML score 2 (original magnification 200x) and (B) NOX2 (original 
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Figure 2: lmmunohistochemical score of CML in the intramyocardial vasculature of heart tissue of control rats (control, n=7), rats with AMI without therapy 
(no therapy, n=6) and rats with AMI with therapy, respectively Stem Bells at day 1 (SIB day 1, n=8), day 7 (SIB day 7, n=9) and day 1 + 7 (SIB day 1 + 7, n=7). 
A: lmmunohistochemical score of CML. Number of the CML positive blood vessels/ mm2 in B: minor staining intensity (score 1); C: moderate staining 
intensity (score 2) and D: strong staining intensity (score 3). Bars represent mean +/- SE. Arcs with * represent significant differences (P<0.05). 
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Figure 3: Quantitative analysis of NOX2 positive blood vessels at day 42 postAMI, compared between control rats (n=7), rats with AMI without therapy (n=6) 
and rats with AMI plus therapy, respectively StemBells applied at day 1 (n=B), day 7 (n=9) and day 1 + 7 (n=7). Bars represent mean +/- SE blood vessels 
positive for NOX2 Arcs with • represent significant differences (P<0.05). 
Discussion 
AMI can result in heart failure in which post-AMI inflammation is playing an important role [20,21]. In the present study we have found that AMI induced an increased accumulation of CML and of NOX2 in the intramyocardial vasculature. This increase was significantly decreased by StemBell (StB) therapy, irrespective of the time point of StB application. 
Previously we have shown that microvascular CML levels were increased in the heart ofrats on day 5 after AMI [18]. In the present study we observed increased levels of CML and NOX2 in the small intramyocardial blood vessels 42 days after the induction of AMI, indicating that this AMI-induced increase in CML is present for an extended time. Similarly, in patients who died from AMI, increased CML levels in the intramyocardial arteries were observed both in acute and chronic phase after AMI [18]. Moreover, as was found previously in the rat and patient study [18], the increased presence of CML, as well as NOX2, was not limited to the infarct area but was observed throughout the ventricles in the non-infarcted myocardium. In patients with diastolic heart failure CML levels were increased in the cardia microvasculature [22] and were associated with the clinical severity and outcome in heart failure patients [23,24]. Also, endothelial-specific overexpression of NOX2 was shown to induce hypertrophy, fibrosis in angiotensin II-treated mice leading to diastolic dysfunction [25]. Taken together, these observations may point to a role for microvascular CML and NOX2 in the chronic remodeling of the heart after AMI. 
Mesenchymal Stem Cells secrete paracrine factors, which can reduce cell death, fibrosis and inflammation after AMI [26-28]. We now found that STBs decreased the AMI-induced pro- inflammatory status of the intramyocardial vasculature [18,29,30] as detected/ indicated by a decrease of CML and NOX2 positivity in the intra­myocardial blood vessels. We analyzed heart tissue from a previous rat study in which we found that StB therapy improved cardiac function without having an effect on infarct size [ 15]. The finding that 
StB therapy did reduce both CML and NOX2 in the intramyocardial vasculature could indicate that the improvement of cardiac function by STB is due, at least partly, by a reduction of the pro-inflammatory status of the heart after AMI. Indeed, in a clinical study a correlation was found between elevated serum CML levels and the severity and mortality in heart failure, at least in diabetes [24]. Furthermore, it was shown that individuals with a high AGE serum levels have an 5-fold increased risk of post-infarction HF [31,32]. The observed reduction of NOX2 positive blood vessels by StBs therapy in theory could also explain its beneficial effect on heart function. 
The long-term cardiac function improvement of StB administration in a rat AMI model was independent of the time point of StB administration [ 16]. Although it was suggested that application of stem cells at an early time point post AMI is less effective related to the detrimental cardiac inflammatory response [33,34]. We found however that even early application of StB therapy resulted in decreased NOX2 expression and CML immunohistochemical score. Indeed, Richardson [35] also demonstrated in a rat model of AMI that repeated bone marrow-derived MSC intervention in both the acute (immediately after AMI) and the sub-acute period (1 week after AMI) resulted in additional improvement of ventricular function beyond single dose, including an increase in arteriolar density in the infarct zone and remote segments. 
Conclusion 
In conclusion, we show that early StB application reduced CML and NOX2 positivity of the intra myocardial vasculature and as such might prevent heart failure development post Ml. 
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je binnen en buiten de gebruikelijke werktijden en zelfs als het niet direct je eigen studie betrof. 
Dank daarvoor. Een dergelijke inzet is te bewonderen. 
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van de "one step procedure" .Ik: heb je leren kennen als een zeer charismatisch mens, die soms 
aan het eind van de middag het pathologielaboratorium binnenstormde en iedereen binnen 
enkele seconden enthousiast kon maken voor nieuwe ideeen en onderzoeken. 
Van het ASI-lab ik ben veel dank verschuldigd aan Alexander, Marjon, Liesbeth en Rieneke. 
Dank voor jullie ondersteuning en de leuke tijd. Het was altijd erg ontspannen en <lat had ik 
ook gewoon nodig. 
Beste Jetty, Youri, Josine, Rieneke, Marlene, Saskia C., Saskia S., Bart, Joost en Kirsten. 
Als AIOS hadden wij een werkkamer. Dit was voor mij een zeer mooie en memorabele tijd. 
Nadat ik voor opleiding naar het ziekenhuis vertrokken was, heb ik van mijn kant weinig laten 
horen. 1k: ben helaas ingehaald door de sleur van het dagelijks leven, maar wil jullie na al deze 
tijd hierbij bedanken voor de mooie herinneringen, zoals het AIOS weekend, de VU­
filmavonden maar ook de leuke gesprekken. Het is altijd fijn geweest om jullie om mij heen te 
hebben. 
Beste Tabitha, dank voor jouw kritische input voor de experimenten en voor de ontzettend 
leuke Douwe Egberts momenten ("heavenly hazel" toch de lekkerste denk ik). 
Dr. Zandieh Doulabi, beste Bherouz, dank voor al je hulp, je kritische input en voor je 
legendarische barbecue. 
Dr. Marlene Knippenberg, wij zijn precies op dezelfde <lag begonnen met het onderzoek en ik 
moet zeggen <lat het zonder jou veel minder leuk en gezellig zou zijn geweest. Dank voor je 
ondersteuning. Het heeft de tijd veel leuker gemaakt. 
Umit en Reindert, dank voor jullie bijdrage aan de laatste twee stukken. Het waren de laatste 
loodjes. Umit ik wens jou heel veel succes toe met de verdediging van jouw proefschrift 
binnenkort. 
Begonia, Marianna, Edith, Arash, Judith, Christoff, Pierre, Alexie en stafleden 
Pathologie VUmc en Kennemer gasthuis dank voor de leuke tijd. Jullie zijn lijdend voor mijn 
VU-tijd geweest. 
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Murat, dank voor jouw hulp tijdens het onderzoek en de gezellige momenten tijdens de 
pathologie opleiding. Helaas zijn wij uiteindelijk geen directe collega's meer geworden, 
maar heb je de liefde in het bedrijfsleven gevonden. Ik denk dat het je heel goed past en met 
referte naar het dankwoord in jouw proefschrift" thats it guys ...... ". 
Collegae van de Treant zorggroep, Meander medisch centrum en Pathan, dank voor jullie 
input en ondersteuning. 
Ik wil alle leden van de leescommissie (prof. Van der Wal, prof. Sluijter, dr. Ulrich, prof.
Rossum, dr. Voermans en dr. Hazen berg) bedanken voor alle tijd en aandacht die jullie aan 
mijn proefschrift hebben geschonken. 
Naast een professionele carriere zijn ook de ontspannen sociale activiteiten hard nodig en 
minstens even belangrijk. Azem, lgander, Anil, Roy, Marc, Eric, Soedhir, Jaiwan, Robert,
Roshad, Kareem, Robin, Gideon, Gerard, Navin, Jeroen, Vikash, Kenneth, Perkash, 
Viren, Sameer, Roela en Ricardo. Dank voor het leuke sociale programma afgelopen jaren. 
Beste Rakesh al vanaf het 1 e jr geneeskunde was er een al directe klik en ook nu bijna 25 jaar 
, enkele avonturen in binnen en buitenland en inmiddels ook een aantal kinderen verder @ 
zijn wij nog steeds dikke vrienden. Hopelijk komt er nu meer tijd vrij voor nog meer leuke 
momenten (met goed eten en goede rum). 
Oom Henkie u bent veel te snel heengegaan, maar was altijd nieuwsgierig naar het onderzoek. 
Ik denk aan u en heb van u geleerd om in dit leven maximaal en van elk moment dat ons gegund 
is met vrienden en familie te genieten. 
Kris en Rishi, nu dit afgerond is, komt er automatisch meer tijd vrij voor meer filmavonden 
(voel een Star Wars ofMarvelmarathon alweer aankomen). Oom Shekar dank voor uw steun 
en getoonde belangstelling. 
Opa Nandoe Tewarie, Adja, ben nog steeds erg dankbaar dat u op mijn pad bent gekomen als 
een religieuze kompas. Ik neem uw wijze woorden altijd mee. 
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